| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 3.46e-05 | 8 | 181 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 7.33e-05 | 10 | 181 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 2.17e-04 | 14 | 181 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 4.73e-04 | 18 | 181 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | lateral element | 5.59e-04 | 19 | 181 | 3 | GO:0000800 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 6.53e-04 | 20 | 181 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | katanin complex | 7.33e-04 | 5 | 181 | 2 | GO:0008352 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 7.57e-04 | 21 | 181 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | gamma-tubulin complex | 7.57e-04 | 21 | 181 | 3 | GO:0000930 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 6.46e-05 | 26 | 120 | 4 | MM15297 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA | 7.53e-05 | 27 | 120 | 4 | M27586 | |
| Pathway | WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM | 1.02e-04 | 55 | 120 | 5 | M39598 | |
| Pubmed | RGPD4 USP34 RANBP2 HIVEP1 ZNF280D MYCBP2 LRRC49 UBR4 CHD7 ZBTB1 JMJD1C DST RESF1 BRCA2 TLE1 TLE3 RGPD3 TNRC6A ANKRD17 CRYBG3 CAMSAP1 ZMYM4 WDR62 KNL1 MYBL2 | 5.38e-19 | 418 | 186 | 25 | 34709266 | |
| Pubmed | USP34 AGAP5 UBAP2 VWA8 FNBP4 XPO4 SMG5 ARHGAP11A DICER1 DST MAST4 PSME4 LMO7 TNRC6A TMEM131L ANKRD17 AGAP9 GARRE1 ZMYM4 PPP6R3 | 1.05e-11 | 529 | 186 | 20 | 14621295 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EPRS1 RANBP2 HIVEP1 UBAP2 BAZ2B ATAD5 FNBP4 ZNF207 CHD7 JMJD1C BLM RIF1 BBX BRCA1 BRCA2 ATXN2 MARF1 UTP3 MBD4 NOP2 ZNF281 ZMYM4 KNL1 MYBL2 C1orf174 | 6.56e-11 | 954 | 186 | 25 | 36373674 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 SYNRG HIVEP1 SH3RF1 MAP1A MYO9B CHD7 BLM RESF1 BRCA2 LMO7 PRDX3 TNRC6A CRYBG3 CLSPN GARRE1 ZMYM4 KNL1 PPP6R3 MYBL2 | 6.86e-11 | 588 | 186 | 20 | 38580884 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EPRS1 RANBP2 BAZ2B ATAD5 LEMD2 FNBP4 CHD7 ARHGAP11A WDR76 INTS3 JMJD1C KIF20A BLM RIF1 DST BBX BRCA1 HOXD9 LMO7 RGPD3 SMU1 EXO1 MBD4 NOP2 ZNF281 ZMYM4 MYBL2 C1orf174 | 3.42e-10 | 1294 | 186 | 28 | 30804502 |
| Pubmed | HIVEP1 UBAP2 ATAD5 LRRC49 UBR4 CHD7 SMG5 ZBTB1 JMJD1C BLM RIF1 DST BBX RESF1 BRCA1 ATXN2 TLE1 TLE3 PRDX3 TNRC6A ZNF66 MARF1 ANKRD17 NOP2 ZNF281 GARRE1 ZMYM4 PPP6R3 MYBL2 | 6.98e-10 | 1429 | 186 | 29 | 35140242 | |
| Pubmed | COG2 MYCBP2 ATAD5 DICER1 JMJD1C TNRC6A ANKRD17 CLSPN CAMSAP1 ZNF281 GARRE1 KNL1 MYBL2 | 7.47e-10 | 242 | 186 | 13 | 34011540 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | HIVEP1 ZNF280D BAZ2B ATAD5 CHD7 ARHGAP11A WDR76 JMJD1C KIF20A BLM RIF1 BBX BRCA1 MBD4 NOP2 ZNF281 ZMYM4 ZNF292 MYBL2 | 8.61e-10 | 608 | 186 | 19 | 36089195 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBR1 EPRS1 SYNRG RANBP2 HIVEP1 MYCBP2 FNBP4 CHD7 INTS3 BLM RIF1 LMO7 TLE3 EXO1 ANKRD17 NOP2 ZMYM4 AGTPBP1 WDR62 PPP6R3 MYBL2 | 1.34e-09 | 774 | 186 | 21 | 15302935 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SYNRG RANBP2 UBAP2 MAP1A MYCBP2 ATAD5 SMG5 DICER1 KIF20A BRCA1 ATXN2 LMO7 TNRC6A MARF1 ANKRD17 CAMSAP1 NOP2 ZNF281 AGTPBP1 ZNF292 | 2.50e-09 | 724 | 186 | 20 | 36232890 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SYNRG HIVEP1 UBAP2 SH3RF1 MYCBP2 SIK1 DST RESF1 MAST4 LMO7 EXO1 ANKRD17 NUMB TNFAIP3 CRYBG3 CAMSAP1 PLK4 GARRE1 ABTB2 WDR62 MTSS2 | 8.64e-09 | 861 | 186 | 21 | 36931259 |
| Pubmed | 1.37e-08 | 116 | 186 | 9 | 30804394 | ||
| Pubmed | SYNRG MAP1A DICER1 PRUNE1 DST MAST4 TNRC6A CRYBG3 CAMSAP1 WDR62 PPP6R3 | 1.94e-08 | 209 | 186 | 11 | 36779422 | |
| Pubmed | USP34 IL16 MAP1A VWA8 ATAD5 ASH1L PER1 EZH1 TEP1 DICER1 KIF20A RESF1 BRCA1 CCNB3 TNRC6A ANKRD17 CRYBG3 CLSPN ZNF281 GARRE1 AGTPBP1 WDR62 KNL1 | 3.63e-08 | 1116 | 186 | 23 | 31753913 | |
| Pubmed | PARylation of BRCA1 limits DNA break resection through BRCA2 and EXO1. | 1.51e-07 | 3 | 186 | 3 | 36735534 | |
| Pubmed | Germline mutations of DICER1 in Chinese women with BRCA1/BRCA2-negative familial breast cancer. | 1.51e-07 | 3 | 186 | 3 | 25526195 | |
| Pubmed | RANBP2 BAZ2B ARHGAP11A BLM RESF1 BRCA1 BRCA2 ZNF281 ZMYM4 MYBL2 | 3.68e-07 | 222 | 186 | 10 | 37071664 | |
| Pubmed | EPRS1 RANBP2 HIVEP1 MYCBP2 DOCK8 BAZ2B ZNF207 CHD7 JMJD1C RESF1 BRCA1 ATXN2 TLE3 SMU1 NOP2 ZNF281 ZMYM4 ZNF286A KNL1 ZNF292 MYBL2 | 5.43e-07 | 1103 | 186 | 21 | 34189442 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | DOCK1 EPRS1 RANBP2 PER1 KIF20A CLSPN ZNF281 GARRE1 WDR62 KNL1 | 5.51e-07 | 232 | 186 | 10 | 25515538 |
| Pubmed | 6.00e-07 | 4 | 186 | 3 | 15726604 | ||
| Pubmed | 6.00e-07 | 4 | 186 | 3 | 22789542 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | RANBP2 UBAP2 MYCBP2 FNBP4 ZBTB1 DICER1 KIF20A BLM ANKRD17 UTP3 CAMSAP1 NOP2 PPP6R3 | 8.22e-07 | 440 | 186 | 13 | 34244565 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SYNRG RANBP2 MAP1A MAMLD1 ZNF207 JMJD1C BLM RESF1 BRCA2 TLE3 RGPD3 ZNF281 ZMYM4 | 9.10e-07 | 444 | 186 | 13 | 34795231 |
| Pubmed | 1.49e-06 | 5 | 186 | 3 | 28191889 | ||
| Pubmed | 1.49e-06 | 5 | 186 | 3 | 38244928 | ||
| Pubmed | RANBP2 SH3RF1 JMJD1C AP4E1 ATXN2 TNRC6A TMEM131L NUMB CRYBG3 CAMSAP1 | 1.72e-06 | 263 | 186 | 10 | 34702444 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.84e-06 | 153 | 186 | 8 | 26365490 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 SYNRG SH3RF1 MYCBP2 VWA8 MYO9B UBR4 PER1 PANX1 SMG5 TEP1 DACT1 DST PSME4 TNFAIP3 CAMSAP1 ULK2 TTC38 ABTB2 MYBL2 | 2.22e-06 | 1105 | 186 | 20 | 35748872 |
| Pubmed | 2.97e-06 | 6 | 186 | 3 | 21459848 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPRS1 SYNRG RANBP2 UBAP2 MAP1A ATAD5 FABP5 PRUNE1 RIF1 DST ANKRD17 NUMB CAMSAP1 NOP2 ZNF281 WDR62 KNL1 PPP6R3 | 3.11e-06 | 934 | 186 | 18 | 33916271 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | RANBP2 MYO9B UBR4 PER1 SMG5 INTS3 JMJD1C BLM RIF1 BBX TLE1 TLE3 ANKRD17 CAMSAP1 ZMYM4 AGTPBP1 MYBL2 | 4.05e-06 | 857 | 186 | 17 | 25609649 |
| Pubmed | THAP5 HIVEP1 MYCBP2 DOCK8 UBR4 ASH1L FNBP4 HIPK3 DST MAST4 TNFAIP3 CAMSAP1 SDK1 KNL1 | 4.09e-06 | 591 | 186 | 14 | 15231748 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | EPM2A HIVEP1 MYCBP2 ABCA13 UBR4 KATNA1 GRM6 JMJD1C LMO7 CAMSAP1 ZMYM4 | 4.39e-06 | 361 | 186 | 11 | 26167880 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 4.71e-06 | 123 | 186 | 7 | 26912792 | |
| Pubmed | 5.03e-06 | 233 | 186 | 9 | 37704626 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 9037092 | ||
| Pubmed | A genome-wide association study of carotid atherosclerosis in HIV-infected men. | 5.19e-06 | 7 | 186 | 3 | 20009918 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 5.19e-06 | 7 | 186 | 3 | 11353387 | |
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 30944974 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 5.19e-06 | 7 | 186 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 5.19e-06 | 7 | 186 | 3 | 17372272 | |
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 38657106 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 21205196 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 18949001 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 25187515 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 8603673 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 26632511 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 24403063 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 23818861 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 23536549 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 12191015 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 22821000 | ||
| Pubmed | 5.19e-06 | 7 | 186 | 3 | 20682751 | ||
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 5.24e-06 | 125 | 186 | 7 | 32891193 | |
| Pubmed | 5.37e-06 | 22 | 186 | 4 | 18095154 | ||
| Pubmed | RANBP2 KATNAL2 ATAD5 ZNF207 CHD7 DICER1 BLM RIF1 DST BBX BRCA1 ATXN2 RGPD3 TNRC6A SMU1 ANKRD17 NUMB UTP3 MBD4 ZNF281 EIF2AK2 ZMYM4 PPP6R3 | 5.72e-06 | 1497 | 186 | 23 | 31527615 | |
| Pubmed | 5.79e-06 | 83 | 186 | 6 | 28794006 | ||
| Pubmed | USP34 ATAD5 ZNF207 INTS3 ZBTB1 JMJD1C BLM RIF1 BRCA1 BRCA2 ZNF281 KNL1 | 6.68e-06 | 453 | 186 | 12 | 29656893 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | USP34 LEMD2 MAMLD1 ZNF207 JMJD1C RIF1 ATXN2 TLE1 TLE3 RGPD3 TNRC6A ANKRD17 | 7.30e-06 | 457 | 186 | 12 | 32344865 |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 8.26e-06 | 8 | 186 | 3 | 21670213 | |
| Pubmed | 8.26e-06 | 8 | 186 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 8.26e-06 | 8 | 186 | 3 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 8.26e-06 | 8 | 186 | 3 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 8.26e-06 | 8 | 186 | 3 | 28745977 | |
| Pubmed | USP34 UBAP2 MYCBP2 CHD7 DICER1 JMJD1C TLE1 TNRC6A TMEM131L CLSPN CAMSAP1 AGTPBP1 WDR62 KNL1 MYBL2 | 1.06e-05 | 733 | 186 | 15 | 34672954 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.23e-05 | 9 | 186 | 3 | 18394993 | |
| Pubmed | 1.23e-05 | 9 | 186 | 3 | 28100513 | ||
| Pubmed | 1.23e-05 | 9 | 186 | 3 | 17887960 | ||
| Pubmed | 1.23e-05 | 9 | 186 | 3 | 11553612 | ||
| Pubmed | Phosphorylation of EXO1 by CDKs 1 and 2 regulates DNA end resection and repair pathway choice. | 1.23e-05 | 9 | 186 | 3 | 24705021 | |
| Pubmed | 1.23e-05 | 9 | 186 | 3 | 10601307 | ||
| Pubmed | 1.23e-05 | 9 | 186 | 3 | 9733766 | ||
| Pubmed | 1.23e-05 | 9 | 186 | 3 | 28877029 | ||
| Pubmed | RGPD4 RANBP2 ABCA13 ATAD5 GC ZBTB1 FABP5 BLM RIF1 BRCA1 BRCA2 LMO7 SMU1 NOP2 | 1.24e-05 | 652 | 186 | 14 | 31180492 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SYNRG ZC3H12A PDE4B DYNC2I2 PER1 OSER1 SIK1 ZBTB1 KIF20A AP4E1 SMU1 KNDC1 NUMB CLSPN ABTB2 AGTPBP1 PPP6R3 C1orf174 | 1.31e-05 | 1038 | 186 | 18 | 26673895 |
| Pubmed | 1.44e-05 | 335 | 186 | 10 | 15741177 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.45e-05 | 146 | 186 | 7 | 23892456 | |
| Pubmed | 1.47e-05 | 28 | 186 | 4 | 17041588 | ||
| Pubmed | RANBP2 MYCBP2 ATAD5 XPO4 BLM RIF1 ATXN2 TLE3 VPS13A TNRC6A KCNMA1 NUMB CRYBG3 UTP3 PLK4 AGTPBP1 KNL1 PPP6R3 | 1.50e-05 | 1049 | 186 | 18 | 27880917 | |
| Pubmed | EPRS1 UBAP2 VWA8 FNBP4 ZNF207 CHD7 WDR76 DICER1 RIF1 ATXN2 LMO7 PRDX3 TNRC6A MARF1 SMU1 ANKRD17 NUMB NOP2 EIF2AK2 AGTPBP1 C1orf174 | 1.57e-05 | 1371 | 186 | 21 | 36244648 | |
| Pubmed | 1.59e-05 | 339 | 186 | 10 | 30415952 | ||
| Pubmed | 1.60e-05 | 99 | 186 | 6 | 27746211 | ||
| Pubmed | 1.76e-05 | 10 | 186 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.76e-05 | 10 | 186 | 3 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.76e-05 | 10 | 186 | 3 | 8857542 | |
| Pubmed | 1.76e-05 | 10 | 186 | 3 | 21859863 | ||
| Pubmed | RGPD4 RANBP2 PDE4B UBAP2 MYCBP2 UBR4 CHD7 ZBTB1 DST ATXN2 SPHKAP RGPD3 KCNMA1 ANKRD17 CAMSAP1 NOP2 MTSS2 | 1.83e-05 | 963 | 186 | 17 | 28671696 | |
| Pubmed | 1.88e-05 | 210 | 186 | 8 | 16565220 | ||
| Pubmed | 1.96e-05 | 153 | 186 | 7 | 10718198 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 2.01e-05 | 212 | 186 | 8 | 33853758 | |
| Pubmed | SPATA7 USP34 KIF20A BLM AP4E1 RIF1 DST BBX BRCA1 VPS13A TNRC6A CLSPN CAMSAP1 NOP2 SDK1 | 2.09e-05 | 777 | 186 | 15 | 35844135 | |
| Pubmed | 2.41e-05 | 11 | 186 | 3 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 2.41e-05 | 11 | 186 | 3 | 35771867 | |
| Pubmed | 2.41e-05 | 11 | 186 | 3 | 34110283 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 2.48e-05 | 357 | 186 | 10 | 37059091 | |
| Pubmed | Association of BRCA1/2 mutations with ovarian cancer prognosis: An updated meta-analysis. | 2.84e-05 | 2 | 186 | 2 | 29480828 | |
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 17924331 | ||
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 12833555 | ||
| Pubmed | Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation. | 2.84e-05 | 2 | 186 | 2 | 14735173 | |
| Interaction | NUP43 interactions | USP34 RANBP2 HIVEP1 ZNF280D AVPR2 BAZ2B ASH1L JMJD1C BLM RIF1 DST BBX RESF1 BRCA1 BRCA2 MARF1 UTP3 ZNF281 ZMYM4 KNL1 ZNF292 MYBL2 | 6.01e-08 | 625 | 183 | 22 | int:NUP43 |
| Interaction | PHF21A interactions | USP34 RANBP2 HIVEP1 MYCBP2 LRRC49 UBR4 CHD7 ZBTB1 JMJD1C DST RESF1 BRCA2 TNRC6A CRYBG3 WDR62 KNL1 | 1.03e-07 | 343 | 183 | 16 | int:PHF21A |
| Interaction | KDM1A interactions | USP34 RANBP2 IL16 HIVEP1 ZNF280D MYCBP2 LRRC49 UBR4 CHD7 WDR76 ZBTB1 JMJD1C DST RESF1 BRCA1 BRCA2 TLE3 TNRC6A ANKRD17 CRYBG3 CAMSAP1 MBD4 ZMYM4 WDR62 KNL1 PPP6R3 MYBL2 | 1.14e-07 | 941 | 183 | 27 | int:KDM1A |
| Interaction | RCOR1 interactions | USP34 RANBP2 HIVEP1 MYCBP2 LRRC49 UBR4 CHD7 ZBTB1 JMJD1C DST RESF1 BRCA2 ANKRD17 CAMSAP1 ZMYM4 WDR62 KNL1 PPP6R3 | 6.29e-07 | 494 | 183 | 18 | int:RCOR1 |
| Interaction | H3C3 interactions | HIVEP1 ZNF280D BAZ2B ATAD5 CHD7 ARHGAP11A WDR76 JMJD1C KIF20A BLM RIF1 BBX BRCA1 MBD4 NOP2 ZNF281 ZMYM4 ZNF292 | 6.48e-07 | 495 | 183 | 18 | int:H3C3 |
| Interaction | SMC5 interactions | EPRS1 RANBP2 HIVEP1 UBAP2 BAZ2B ATAD5 FNBP4 ZNF207 CHD7 JMJD1C BLM RIF1 BBX BRCA1 BRCA2 ATXN2 MARF1 UTP3 MBD4 NOP2 ZNF281 ZMYM4 KNL1 MYBL2 C1orf174 | 4.26e-06 | 1000 | 183 | 25 | int:SMC5 |
| Interaction | H2BC8 interactions | ZNF280D ATAD5 CHD7 ARHGAP11A WDR76 INTS3 KIF20A BLM RIF1 BBX BRCA1 UTP3 MBD4 ZNF281 ZMYM4 ZNF292 MYBL2 C1orf174 | 5.48e-06 | 576 | 183 | 18 | int:H2BC8 |
| Interaction | FBXO38 interactions | 7.24e-06 | 145 | 183 | 9 | int:FBXO38 | |
| Interaction | H3C1 interactions | EPRS1 ZNF280D ATAD5 UBR4 ASH1L CHD7 ARHGAP11A WDR76 JMJD1C BLM RIF1 BBX CCNB3 TLE3 PCDH11X SMU1 UTP3 CAMSAP1 NOP2 ZNF281 ZMYM4 ZNF292 C1orf174 | 7.63e-06 | 901 | 183 | 23 | int:H3C1 |
| Interaction | GATA3 interactions | 8.40e-06 | 187 | 183 | 10 | int:GATA3 | |
| Interaction | H3-3A interactions | EPRS1 HIVEP1 ZNF280D DYNC2I2 ATAD5 ASH1L CHD7 ARHGAP11A WDR76 JMJD1C BLM RIF1 BBX BRCA1 MBD4 ZNF281 ZMYM4 PPP6R3 ZNF292 MYBL2 | 1.65e-05 | 749 | 183 | 20 | int:H3-3A |
| Interaction | ASF1A interactions | HIVEP1 ATAD5 CHD7 FABP5 BLM RIF1 BRCA1 BRCA2 CLSPN ZNF281 MYBL2 | 1.80e-05 | 249 | 183 | 11 | int:ASF1A |
| Interaction | POLR1E interactions | RANBP2 HIVEP1 BAZ2B ATAD5 LRRC49 CHD7 BLM BBX BRCA2 UTP3 ZMYM4 AGTPBP1 ZNF292 | 1.98e-05 | 350 | 183 | 13 | int:POLR1E |
| Interaction | H2BC21 interactions | EPRS1 ZNF280D ATAD5 FNBP4 SIK1 CHD7 SMG5 WDR76 INTS3 JMJD1C KIF20A BLM RIF1 BRCA1 SMU1 EXO1 NOP2 ZMYM4 ZNF292 | 2.00e-05 | 696 | 183 | 19 | int:H2BC21 |
| Interaction | CBX3 interactions | ZNF280D ATAD5 CHD7 EZH1 WDR76 ZNF568 KIF20A BLM RIF1 BBX BRCA1 ZNF91 CLSPN ZNF281 ZMYM4 KNL1 ZNF292 MYBL2 | 2.56e-05 | 646 | 183 | 18 | int:CBX3 |
| Interaction | LYPD6B interactions | 2.62e-05 | 39 | 183 | 5 | int:LYPD6B | |
| Interaction | RTL9 interactions | 3.49e-05 | 21 | 183 | 4 | int:RTL9 | |
| Interaction | SMG7 interactions | HIVEP1 SMG5 JMJD1C BRCA1 ATXN2 TLE1 TLE3 TNRC6A ANKRD17 CLSPN GARRE1 ABTB2 | 3.67e-05 | 319 | 183 | 12 | int:SMG7 |
| Interaction | RGPD4 interactions | 4.23e-05 | 22 | 183 | 4 | int:RGPD4 | |
| Interaction | EGLN3 interactions | USP34 RANBP2 KATNAL2 UBAP2 MYCBP2 VWA8 UBR4 SMG5 ZBTB1 DICER1 JMJD1C BLM BRCA1 BRCA2 ATXN2 PRDX3 EXO1 ANKRD17 NUMB CLSPN CAMSAP1 ZNF281 WDR62 KNL1 PPP6R3 MYBL2 C1orf174 | 4.52e-05 | 1296 | 183 | 27 | int:EGLN3 |
| Interaction | TERF2IP interactions | HIVEP1 ATAD5 CHD7 BLM RIF1 BBX BRCA1 BRCA2 CLSPN ZNF281 ZMYM4 KNL1 PPP6R3 ZNF292 MYBL2 C1orf174 | 4.60e-05 | 552 | 183 | 16 | int:TERF2IP |
| Interaction | CNOT9 interactions | UBAP2 SMG5 JMJD1C ATXN2 TNRC6A MARF1 TMEM131L ANKRD17 GARRE1 MYBL2 | 5.17e-05 | 231 | 183 | 10 | int:CNOT9 |
| Interaction | ARL4D interactions | 5.75e-05 | 146 | 183 | 8 | int:ARL4D | |
| Interaction | PFN1 interactions | DOCK1 SYNRG MAP9 RANBP2 MAP1A DOCK8 MYO9B FABP5 BRCA1 TLE1 PRDX3 CRYBG3 ZMYM4 WDR62 MTSS2 | 6.65e-05 | 509 | 183 | 15 | int:PFN1 |
| Interaction | TERF2 interactions | NEXMIF TRPC5 CHD7 TEP1 BLM DST BRCA1 BRCA2 PRDX3 MARF1 NUMB ZNF281 | 6.78e-05 | 340 | 183 | 12 | int:TERF2 |
| Interaction | HDAC1 interactions | RANBP2 HIVEP1 MYCBP2 LRRC49 UBR4 WDR76 ZBTB1 JMJD1C KIF20A DACT1 DST BBX BRCA1 BRCA2 LMO7 TLE1 TLE3 TNRC6A ANKRD17 CRYBG3 CAMSAP1 MBD4 KNL1 PPP6R3 | 6.86e-05 | 1108 | 183 | 24 | int:HDAC1 |
| Interaction | TBR1 interactions | 7.80e-05 | 113 | 183 | 7 | int:TBR1 | |
| Interaction | FOXL1 interactions | 7.86e-05 | 196 | 183 | 9 | int:FOXL1 | |
| Interaction | SOX2 interactions | USP34 EPRS1 RANBP2 HIVEP1 MAP1A MYO9B BAZ2B ATAD5 UBR4 LEMD2 XPO4 CHD7 INTS3 JMJD1C FABP5 TLE1 TLE3 TNRC6A MARF1 ANKRD17 NUMB UTP3 NOP2 ZNF281 EIF2AK2 KNL1 ZNF292 MYBL2 | 8.60e-05 | 1422 | 183 | 28 | int:SOX2 |
| Interaction | SOX7 interactions | 1.02e-04 | 82 | 183 | 6 | int:SOX7 | |
| Interaction | QPRT interactions | 1.17e-04 | 84 | 183 | 6 | int:QPRT | |
| Interaction | GSK3B interactions | UBR1 SYNRG EPM2A MAP1A VWA8 LRRC49 DICER1 PRUNE1 DST MAST4 TLE1 TLE3 TNRC6A TNFAIP3 CRYBG3 CLSPN CAMSAP1 ZNF281 WDR62 PPP6R3 | 1.28e-04 | 868 | 183 | 20 | int:GSK3B |
| Interaction | YWHAB interactions | SYNRG PDE4B HIVEP1 SH3RF1 MYCBP2 SIK1 WDR76 DACT1 DST MAST4 LMO7 PRDX3 KCNMA1 EXO1 ANKRD17 NUMB TNFAIP3 CAMSAP1 PLK4 GARRE1 WDR62 MTSS2 | 1.38e-04 | 1014 | 183 | 22 | int:YWHAB |
| Interaction | POLR1G interactions | BAZ2B ATAD5 UBR4 CHD7 KIF20A BLM BBX UTP3 CLSPN NOP2 ZNF281 ZMYM4 AGTPBP1 ZNF292 | 1.58e-04 | 489 | 183 | 14 | int:POLR1G |
| Interaction | ISX interactions | 1.71e-04 | 31 | 183 | 4 | int:ISX | |
| Interaction | CEP135 interactions | LRRC49 KIF20A DACT1 BRCA2 LMO7 TNRC6A TMEM131L CAMSAP1 ULK2 ZMYM4 | 1.99e-04 | 272 | 183 | 10 | int:CEP135 |
| Interaction | SFN interactions | SYNRG SH3RF1 MAP1A MYCBP2 ARHGAP11A DST MAST4 LMO7 EXO1 ANKRD17 NUMB CRYBG3 CAMSAP1 PLK4 GARRE1 WDR62 MTSS2 | 1.99e-04 | 692 | 183 | 17 | int:SFN |
| Interaction | MYB interactions | 2.16e-04 | 133 | 183 | 7 | int:MYB | |
| Interaction | OLIG1 interactions | 2.19e-04 | 33 | 183 | 4 | int:OLIG1 | |
| Interaction | TOPAZ1 interactions | 2.49e-04 | 14 | 183 | 3 | int:TOPAZ1 | |
| GeneFamily | WD repeat domain containing | 8.70e-05 | 262 | 125 | 9 | 362 | |
| GeneFamily | Cystatins, type 4 | 1.42e-04 | 3 | 125 | 2 | 968 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 9.73e-04 | 7 | 125 | 2 | 785 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 1.29e-03 | 8 | 125 | 2 | 281 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.63e-03 | 181 | 125 | 6 | 694 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 2.50e-03 | 11 | 125 | 2 | 1025 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK1 USP34 RANBP2 HIVEP1 MYCBP2 MYO9B BAZ2B MAMLD1 ARHGAP11A DICER1 BLM RIF1 DST BBX PSME4 BRCA1 BRCA2 ATXN2 TLE1 VPS13A TMEM131L ANKRD17 NUMB CRYBG3 GARRE1 ZMYM4 ADGRA3 ZNF292 | 1.24e-11 | 856 | 184 | 28 | M4500 |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN | ATAD5 WDR76 KIF20A BLM BRCA1 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 9.41e-08 | 187 | 184 | 11 | M34027 |
| Coexpression | GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP | USP34 IL16 ZC3H12A PDE4B UBR4 MAMLD1 OSER1 EZH1 TNFAIP3 ABTB2 PPP6R3 | 1.68e-07 | 198 | 184 | 11 | M4462 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | HIVEP1 MYCBP2 BAZ2B MAMLD1 BLM DST BBX BRCA1 ATXN2 TLE1 VPS13A MARF1 ANKRD17 NUMB ZMYM4 ZNF292 | 2.12e-07 | 466 | 184 | 16 | M13522 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | DYNC2I2 ATAD5 ARHGAP11A WDR76 BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 5.20e-07 | 323 | 184 | 13 | M2156 |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 5.42e-07 | 43 | 184 | 6 | MM3857 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | UBAP2 DYNC2I2 ATAD5 CHD7 ARHGAP11A WDR76 FABP5 KIF20A BLM RIF1 MAST4 BRCA1 BRCA2 ZNF66 EXO1 CLSPN SPAG16 MBD4 PLK4 WDR62 KNL1 MYBL2 | 8.07e-07 | 939 | 184 | 22 | M45768 |
| Coexpression | GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN | SPATA7 USP34 ZNF280D DOCK8 ABCA13 PANX1 JMJD1C RIF1 MARF1 CLSPN | 1.62e-06 | 200 | 184 | 10 | M7505 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | MYO9B ATAD5 LRRC49 ARHGAP11A WDR76 KIF20A BLM PSME4 BRCA1 BRCA2 EXO1 TNFAIP3 CLSPN PLK4 KNL1 MYBL2 | 2.77e-06 | 567 | 184 | 16 | M45692 |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | KATNAL2 UBAP2 TTC41P MYO9B LRRC49 ARHGAP11A WDR76 INTS3 KIF20A BLM BRCA2 EXO1 UTP3 CLSPN PLK4 KNL1 MYBL2 C1orf174 | 3.15e-06 | 714 | 184 | 18 | M1744 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | THAP5 USP34 EPRS1 RANBP2 MAP1A MYCBP2 NEXMIF ASH1L CHD7 FAM200B DICER1 DST BBX MAST4 P2RY1 ATXN2 KCNMA1 ZNF91 AGTPBP1 MTSS2 ZNF292 | 3.40e-06 | 946 | 184 | 21 | M39169 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BLM CD82 BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 3.93e-06 | 450 | 184 | 14 | M45747 |
| Coexpression | GSE14415_INDUCED_VS_NATURAL_TREG_DN | 5.67e-06 | 181 | 184 | 9 | M2969 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 SORCS2 EXO1 CLSPN EIF2AK2 PLK4 KNL1 | 5.80e-06 | 402 | 184 | 13 | MM454 |
| Coexpression | ODONNELL_TFRC_TARGETS_DN | 6.52e-06 | 139 | 184 | 8 | M6451 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | MAP9 UBAP2 ATAD5 NEXMIF CHD7 ARHGAP11A WDR76 KIF20A BLM RIF1 BRCA2 EXO1 CLSPN CAMSAP1 MBD4 PLK4 KNL1 | 6.69e-06 | 680 | 184 | 17 | MM456 |
| Coexpression | GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN | 6.77e-06 | 185 | 184 | 9 | M2965 | |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 8.40e-06 | 190 | 184 | 9 | M761 | |
| Coexpression | GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP | 1.17e-05 | 198 | 184 | 9 | M8131 | |
| Coexpression | GSE369_IFNG_KO_VS_WT_LIVER_UP | 1.22e-05 | 199 | 184 | 9 | M5970 | |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP | 1.22e-05 | 199 | 184 | 9 | M8396 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | PDE4B HIVEP1 FAM13C ASH1L HIPK3 AP4E1 DST BBX MAST4 LMO7 PTPRO SCN7A VPS13A TNFAIP3 ZNF91 ULK2 ZNF726 GARRE1 TECPR1 | 1.71e-05 | 888 | 184 | 19 | MM1018 |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 2.59e-05 | 168 | 184 | 8 | M18811 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 3.61e-05 | 176 | 184 | 8 | M2981 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | USP34 UBR1 SYNRG RANBP2 IL16 PDE4B WWC3 MYCBP2 DOCK8 MYO9B UBR4 ASH1L FNBP4 XPO4 ITGA1 ITGAL ZBTB1 DICER1 JMJD1C RIF1 BBX RESF1 TMEM131L TNFAIP3 ZNF292 | 4.85e-05 | 1492 | 184 | 25 | M40023 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 5.54e-05 | 187 | 184 | 8 | M2984 | |
| Coexpression | FISCHER_DREAM_TARGETS | ATAD5 FNBP4 ZNF207 KATNA1 ARHGAP11A WDR76 KIF20A BLM RIF1 BRCA1 BRCA2 EXO1 ANKRD17 CLSPN PLK4 WDR62 KNL1 MYBL2 C1orf174 | 5.57e-05 | 969 | 184 | 19 | M149 |
| Coexpression | BENPORATH_CYCLING_GENES | MYCBP2 OSER1 ZNF207 KATNA1 ARHGAP11A JMJD1C BRCA1 TLE3 EXO1 CLSPN MBD4 ZNF281 TTC38 WDR62 PPP6R3 | 5.71e-05 | 648 | 184 | 15 | M8156 |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 5.97e-05 | 189 | 184 | 8 | M3112 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | USP34 EPM2A WWC3 ATAD5 PANX1 CHD7 ARHGAP11A WDR76 DICER1 KIF20A BLM DST BRCA1 BRCA2 CLSPN TCFL5 PLK4 KNL1 | 6.12e-05 | 892 | 184 | 18 | M18120 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | ATAD5 ARHGAP11A WDR76 LGR5 KIF20A BLM RIF1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 6.28e-05 | 578 | 184 | 14 | M2368 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | ZC3H12A HIVEP1 BAZ2B FNBP4 PER1 OSER1 SIK1 EZH1 JMJD1C HIPK3 DST RESF1 TLE1 TLR2 NUMB GARRE1 ABTB2 | 7.34e-05 | 822 | 184 | 17 | M6782 |
| Coexpression | GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_DN | 8.00e-05 | 146 | 184 | 7 | M452 | |
| Coexpression | RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP | 8.71e-05 | 148 | 184 | 7 | M39016 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | ATAD5 ARHGAP11A WDR76 LGR5 KIF20A BLM RIF1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 8.84e-05 | 597 | 184 | 14 | MM1309 |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP | 8.87e-05 | 200 | 184 | 8 | M4590 | |
| Coexpression | GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP | 8.87e-05 | 200 | 184 | 8 | M3675 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 8.87e-05 | 200 | 184 | 8 | M5041 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN | 8.87e-05 | 200 | 184 | 8 | M9215 | |
| Coexpression | GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP | 8.87e-05 | 200 | 184 | 8 | M5723 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | PDE4B HIVEP1 FAM13C ASH1L HIPK3 AP4E1 DST BBX MAST4 LMO7 PTPRO SCN7A VPS13A TNFAIP3 ULK2 GARRE1 TECPR1 | 1.16e-04 | 854 | 184 | 17 | M1533 |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 1.16e-04 | 155 | 184 | 7 | M39041 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | DYNC2I2 ATAD5 ARHGAP11A WDR76 FABP5 KIF20A BLM RIF1 BRCA1 BRCA2 EXO1 CLSPN WDR62 KNL1 MYBL2 | 1.22e-04 | 694 | 184 | 15 | M45767 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | ATAD5 ARHGAP11A WDR76 KIF20A RIF1 BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 1.52e-04 | 478 | 184 | 12 | M45785 |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP | COG2 MAMLD1 CHD7 RYR3 DST TMEM131L ANKRD17 ZNF91 CAMSAP1 AGTPBP1 | 1.54e-04 | 340 | 184 | 10 | M2012 |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 1.65e-04 | 164 | 184 | 7 | M19957 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | ARHGAP11A WDR76 KIF20A BLM CD82 BRCA1 BRCA2 LMO7 SCN7A SORCS2 EXO1 CRYBG3 CLSPN MBD4 PLK4 ABTB2 WDR62 KNL1 MYBL2 | 1.66e-04 | 1054 | 184 | 19 | M45798 |
| Coexpression | GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN | 1.85e-04 | 167 | 184 | 7 | M361 | |
| Coexpression | SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_UP | 1.99e-04 | 169 | 184 | 7 | M40877 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | 2.22e-04 | 290 | 184 | 9 | M45736 | |
| Coexpression | HADDAD_B_LYMPHOCYTE_PROGENITOR | 2.22e-04 | 290 | 184 | 9 | M939 | |
| Coexpression | ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF | 2.46e-04 | 232 | 184 | 8 | M2613 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | RANBP2 ZC3H12A PDE4B PER1 OSER1 CHD7 JMJD1C BBX TLE3 TNFAIP3 MBD4 | 2.54e-04 | 432 | 184 | 11 | M41149 |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | RGPD4 RANBP2 PDE4B FNBP4 CHD7 KATNA1 TLE3 RGPD3 TNFAIP3 ZNF281 ABTB2 | 2.69e-04 | 435 | 184 | 11 | MM1221 |
| Coexpression | FISCHER_G2_M_CELL_CYCLE | 2.75e-04 | 236 | 184 | 8 | M130 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 LMO7 TLE3 EXO1 PLK4 WDR62 KNL1 MYBL2 | 2.80e-04 | 588 | 184 | 13 | M38992 |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION | 2.84e-04 | 82 | 184 | 5 | M16458 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 2.85e-04 | 300 | 184 | 9 | M8702 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | UBR1 ATAD5 NEXMIF LEMD2 XPO4 ZNF207 WDR76 DICER1 BLM PRUNE1 RIF1 BRCA1 BRCA2 PRDX3 EXO1 INSYN2B MBD4 PLK4 QRSL1 KNL1 MYBL2 | 3.00e-04 | 1290 | 184 | 21 | M80 |
| Coexpression | GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_UP | 3.02e-04 | 181 | 184 | 7 | M2994 | |
| Coexpression | ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN | 3.05e-04 | 46 | 184 | 4 | M6792 | |
| Coexpression | BCAT_BILD_ET_AL_DN | 3.05e-04 | 46 | 184 | 4 | M2702 | |
| Coexpression | WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN | 3.10e-04 | 371 | 184 | 10 | M2132 | |
| Coexpression | ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR | 3.18e-04 | 84 | 184 | 5 | M2606 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | NAT1 KATNA1 ARHGAP11A FABP5 BLM RIF1 BRCA1 BRCA2 PRDX3 EXO1 TMEM131L UTP3 NOP2 PLK4 MYBL2 | 3.28e-04 | 761 | 184 | 15 | M11961 |
| Coexpression | GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_UP | 3.34e-04 | 131 | 184 | 6 | M8922 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 3.36e-04 | 85 | 184 | 5 | M10575 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION | 3.36e-04 | 85 | 184 | 5 | MM1106 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | RANBP2 ZC3H12A HIVEP1 FNBP4 PER1 CHD7 DICER1 JMJD1C RIF1 BBX PSME4 MARF1 TNFAIP3 ZNF292 | 3.37e-04 | 680 | 184 | 14 | M41089 |
| Coexpression | GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN | 3.77e-04 | 134 | 184 | 6 | M1896 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN | 3.92e-04 | 189 | 184 | 7 | M8275 | |
| Coexpression | GSE13411_NAIVE_VS_MEMORY_BCELL_UP | 4.30e-04 | 192 | 184 | 7 | M3245 | |
| Coexpression | GSE29618_BCELL_VS_PDC_UP | 4.87e-04 | 196 | 184 | 7 | M4940 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP | 4.87e-04 | 196 | 184 | 7 | M9867 | |
| Coexpression | GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP | 4.87e-04 | 196 | 184 | 7 | M6227 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN | 4.87e-04 | 196 | 184 | 7 | M5778 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_UP | 5.17e-04 | 198 | 184 | 7 | M4586 | |
| Coexpression | GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP | 5.17e-04 | 198 | 184 | 7 | M6217 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN | 5.17e-04 | 198 | 184 | 7 | M6230 | |
| Coexpression | GSE1566_WT_VS_EZH2_KO_LN_TCELL_DN | 5.17e-04 | 198 | 184 | 7 | M6224 | |
| Coexpression | GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN | 5.17e-04 | 198 | 184 | 7 | M5259 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP | 5.33e-04 | 199 | 184 | 7 | M9420 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP | 5.33e-04 | 199 | 184 | 7 | M9410 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN | 5.33e-04 | 199 | 184 | 7 | M9418 | |
| Coexpression | GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_UP | 5.33e-04 | 199 | 184 | 7 | M8324 | |
| Coexpression | GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_DN | 5.33e-04 | 199 | 184 | 7 | M6275 | |
| Coexpression | GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN | 5.33e-04 | 199 | 184 | 7 | M5214 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP | 5.49e-04 | 200 | 184 | 7 | M4604 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN | 5.49e-04 | 200 | 184 | 7 | M8039 | |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | 5.49e-04 | 200 | 184 | 7 | M387 | |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN | 5.49e-04 | 200 | 184 | 7 | M8389 | |
| Coexpression | GSE27786_CD4_TCELL_VS_MONO_MAC_DN | 5.49e-04 | 200 | 184 | 7 | M4834 | |
| Coexpression | GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_DN | 5.49e-04 | 200 | 184 | 7 | M8331 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 5.49e-04 | 200 | 184 | 7 | M3580 | |
| Coexpression | GSE27786_LIN_NEG_VS_NKCELL_DN | 5.49e-04 | 200 | 184 | 7 | M4784 | |
| Coexpression | GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN | 5.49e-04 | 200 | 184 | 7 | M8506 | |
| Coexpression | GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP | 5.49e-04 | 200 | 184 | 7 | M7500 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_UP | 5.49e-04 | 200 | 184 | 7 | M6234 | |
| Coexpression | HALLMARK_TNFA_SIGNALING_VIA_NFKB | 5.49e-04 | 200 | 184 | 7 | M5890 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 5.49e-04 | 200 | 184 | 7 | M5901 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | SPATA7 KATNAL2 FAM185A TTC41P ZNF280D MAP1A ATAD5 NEXMIF MAMLD1 CHD7 LGR5 BLM RIF1 PSME4 BRCA1 BRCA2 PTPRO VPS13A EXO1 TMEM131L ZNF91 CLSPN CAMSAP1 ZNF281 TSLP ULK2 PLK4 WDR62 KNL1 ZNF292 MYBL2 | 1.44e-09 | 1060 | 180 | 31 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_200 | 6.20e-09 | 31 | 180 | 7 | gudmap_developingGonad_e14.5_ ovary_200_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#4_top-relative-expression-ranked_100 | 1.38e-07 | 29 | 180 | 6 | gudmap_developingGonad_e16.5_ovary_100_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | EPRS1 RANBP2 KATNAL2 ATAD5 ZNF207 CHD7 WDR76 ZBTB1 RIF1 BBX BRCA1 BRCA2 TLE3 EXO1 UTP3 CLSPN PLK4 QRSL1 C1orf174 | 1.43e-07 | 532 | 180 | 19 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | EPRS1 RANBP2 KATNAL2 ATAD5 CHD7 WDR76 ZBTB1 KIF20A BRCA2 EXO1 PLK4 QRSL1 | 1.81e-07 | 204 | 180 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | USP34 RBM44 MYOT FAM13C NEXMIF ASH1L ZNF207 TEX15 EZH1 WDR76 LGR5 FETUB RIF1 BBX RESF1 MAST4 LMO7 MARF1 INSYN2B TCFL5 ABTB2 MYBL2 | 6.57e-07 | 770 | 180 | 22 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | USP34 RBM44 NEXMIF ASH1L ZNF207 TEX15 LGR5 JMJD1C RIF1 BBX RESF1 MAST4 BRCA1 BRCA2 CCNB3 VPS13A EXO1 ANKRD17 INSYN2B TCFL5 GARRE1 ABTB2 | 7.47e-07 | 776 | 180 | 22 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_200 | RBM44 NEXMIF ASH1L ZNF207 TEX15 LGR5 RESF1 CCNB3 INSYN2B TCFL5 | 8.47e-07 | 155 | 180 | 10 | gudmap_developingGonad_e16.5_ovary_200 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | SPATA7 KATNAL2 FAM185A TTC41P ZNF280D MAP1A ATAD5 NEXMIF MAMLD1 CHD7 LGR5 BLM RIF1 PSME4 BRCA1 BRCA2 PTPRO VPS13A EXO1 TMEM131L ZNF91 CLSPN CAMSAP1 ZNF281 TSLP ULK2 PLK4 WDR62 KNL1 ZNF292 MYBL2 | 9.70e-07 | 1414 | 180 | 31 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SPATA7 EPRS1 RANBP2 KATNAL2 FAM185A ZNF280D MAP1A ATAD5 MAMLD1 XPO4 CHD7 DICER1 BLM RIF1 BRCA1 BRCA2 VPS13A PCDH11X SCUBE3 EXO1 CLSPN WDR62 KNL1 TECPR1 ZNF292 | 1.02e-06 | 989 | 180 | 25 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | RBM44 SH3RF1 NEXMIF ASH1L FNBP4 XPO4 ZNF207 LGR5 RIF1 BBX RESF1 MAST4 BRCA1 HOXD9 ATXN2 TNRC6A EXO1 ANKRD17 TCFL5 ABTB2 KNL1 MYBL2 | 1.40e-06 | 806 | 180 | 22 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | DOCK1 SPATA7 RANBP2 ATAD5 ZNF207 CHD7 KIF20A RIF1 DST BBX BRCA2 EXO1 UTP3 CLSPN PLK4 ZNF292 | 2.63e-06 | 469 | 180 | 16 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | RANBP2 ZNF280D ATAD5 CHD7 DICER1 BLM RIF1 BRCA1 BRCA2 EXO1 CLSPN KNL1 ZNF292 | 2.68e-06 | 311 | 180 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_200 | 3.53e-06 | 49 | 180 | 6 | gudmap_developingGonad_e18.5_ovary_200_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SPATA7 UBR1 KATNAL2 ZNF280D ATAD5 MAMLD1 CHD7 ZBTB1 RIF1 CD82 BBX BRCA2 NUMB CLSPN ADGRA3 KNL1 MTSS2 ZNF292 | 7.14e-06 | 629 | 180 | 18 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | EPRS1 RANBP2 KATNAL2 ATAD5 ASH1L MAMLD1 CHD7 RIF1 BRCA1 BRCA2 VPS13A SCUBE3 EXO1 ADAMTS20 TMEM131L ZNF91 CLSPN CAMSAP1 AGTPBP1 KNL1 ZNF292 | 8.11e-06 | 831 | 180 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | ATAD5 ARHGAP11A WDR76 LGR5 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN MBD4 PLK4 KNL1 MYBL2 | 1.09e-05 | 409 | 180 | 14 | GSM399452_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_200 | 1.70e-05 | 64 | 180 | 6 | gudmap_developingGonad_e16.5_ovary_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_100 | 1.75e-05 | 19 | 180 | 4 | gudmap_developingGonad_e18.5_ovary_100_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | SPATA7 EPRS1 HIVEP1 ZNF280D MYCBP2 ATAD5 CHD7 ZBTB1 DICER1 JMJD1C AP4E1 ANKRD17 ADGRA3 KNL1 MTSS2 ZNF292 | 2.62e-05 | 564 | 180 | 16 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | RBM44 NEXMIF ASH1L ZNF207 TEX15 LGR5 RIF1 RESF1 MAST4 CCNB3 INSYN2B TCFL5 ABTB2 | 2.77e-05 | 387 | 180 | 13 | gudmap_developingGonad_e18.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_200 | 3.73e-05 | 147 | 180 | 8 | gudmap_developingGonad_e18.5_ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_200 | 3.92e-05 | 148 | 180 | 8 | gudmap_developingGonad_e14.5_ ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_100 | 3.92e-05 | 74 | 180 | 6 | gudmap_developingGonad_e16.5_ovary_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 3.96e-05 | 192 | 180 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | USP34 RBM44 SH3RF1 NEXMIF ASH1L FNBP4 XPO4 ZNF207 TEX15 LGR5 RIF1 BBX RESF1 MAST4 ATXN2 CCNB3 ANKRD17 INSYN2B TCFL5 | 4.79e-05 | 795 | 180 | 19 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | ATAD5 ITGA1 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 5.01e-05 | 410 | 180 | 13 | GSM538387_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#2 | 5.68e-05 | 79 | 180 | 6 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | KATNAL2 IL16 ZNF280D ATAD5 LRRC49 CHD7 LGR5 ZBTB1 BLM IGSF10 AP4E1 RIF1 RESF1 PSME4 BRCA2 P2RY1 VPS13A TMEM131L ZNF91 CLSPN CAMSAP1 ZNF281 PLK4 KNL1 ZNF292 | 5.82e-05 | 1252 | 180 | 25 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | ATAD5 ARHGAP11A WDR76 KIF20A BLM RIF1 BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 5.95e-05 | 417 | 180 | 13 | GSM399403_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | KATNAL2 TTC41P ZNF280D ATAD5 LRRC49 WDR76 DICER1 BLM RIF1 PSME4 BRCA1 BRCA2 TLE1 VPS13A EXO1 TMEM131L UTP3 CLSPN CAMSAP1 ZNF281 PLK4 KNL1 ZNF292 MYBL2 C1orf174 | 6.21e-05 | 1257 | 180 | 25 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | alpha beta T cells, preT.DN2B.Th, Lin-/lo CD25hi CD44+ cKitint, Thymus, avg-2 | ATAD5 SIK1 WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 ADGRA3 KNL1 MYBL2 | 6.40e-05 | 420 | 180 | 13 | GSM791141_500 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | ATAD5 CHD7 ARHGAP11A FABP5 BLM BRCA1 SCUBE3 CLSPN PLK4 ADGRA3 KNL1 | 8.45e-05 | 316 | 180 | 11 | gudmap_kidney_P3_CapMes_Crym_k4_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | RBM44 MYOT NEXMIF ZNF207 TEX15 LGR5 FETUB RIF1 RESF1 MAST4 LMO7 TCFL5 | 9.93e-05 | 379 | 180 | 12 | gudmap_developingGonad_P2_ovary_500 |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 LMO7 EXO1 CLSPN MBD4 PLK4 KNL1 MYBL2 | 1.02e-04 | 380 | 180 | 12 | GSM538207_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | RBM44 NEXMIF ASH1L ZNF207 TEX15 LGR5 RIF1 RESF1 MAST4 CCNB3 INSYN2B TCFL5 | 1.07e-04 | 382 | 180 | 12 | gudmap_developingGonad_e14.5_ ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_500 | 1.25e-04 | 91 | 180 | 6 | gudmap_developingGonad_e14.5_ ovary_500_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | FAM185A NEXMIF CHD7 TEX15 LGR5 DST RESF1 ATXN2 PRDX3 PCDH11X NXF3 TMEM131L NUMB INSYN2B EIF2AK2 TTC38 MTSS2 ZNF292 | 1.41e-04 | 791 | 180 | 18 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.43e-04 | 59 | 180 | 5 | gudmap_developingGonad_e16.5_testes_1000_k2 | |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | ATAD5 ARHGAP11A WDR76 LGR5 KIF20A MAST4 PSME4 BRCA1 SORCS2 TMEM131L CLSPN KNL1 | 1.46e-04 | 395 | 180 | 12 | GSM538340_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.49e-04 | 179 | 180 | 8 | gudmap_developingGonad_e14.5_ ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_500 | 1.49e-04 | 134 | 180 | 7 | gudmap_developingGonad_e18.5_ovary_500_k1 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | ZNF280D ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 | 1.57e-04 | 398 | 180 | 12 | GSM399397_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_100 | 1.61e-04 | 13 | 180 | 3 | gudmap_developingGonad_e14.5_ ovary_100_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.68e-04 | 232 | 180 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | VWA8 NEXMIF CHD7 TEX15 LGR5 DST RESF1 LMO7 PRDX3 PCDH11X NXF3 TMEM131L NUMB INSYN2B EIF2AK2 TTC38 CCDC136 MTSS2 | 1.70e-04 | 803 | 180 | 18 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | Stem Cells, SC.MDP.BM, Sca1- Flt3+ MCSFR+ cKithi, Bone marrow, avg-3 | DOCK1 DYNC2I2 ATAD5 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 1.72e-04 | 402 | 180 | 12 | GSM791105_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | ATAD5 CHD7 ITGA1 ARHGAP11A WDR76 ITGAL KIF20A GARIN3 BRCA1 CLSPN PLK4 KNL1 | 1.72e-04 | 402 | 180 | 12 | GSM605898_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | RBM44 SH3RF1 ZNF280D NEXMIF ASH1L XPO4 ZNF207 JMJD1C RIF1 RESF1 MAST4 ATXN2 SPHKAP PCDH11X EXO1 ANKRD17 INSYN2B TTC38 | 1.73e-04 | 804 | 180 | 18 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | RBM44 SH3RF1 ASH1L XPO4 ZNF207 LGR5 RIF1 RESF1 MAST4 ATXN2 EXO1 ABTB2 | 1.76e-04 | 403 | 180 | 12 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | CHD7 TEX15 LGR5 DST RESF1 PRDX3 PCDH11X NXF3 TMEM131L NUMB TTC38 MTSS2 | 1.80e-04 | 404 | 180 | 12 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | KATNAL2 ATAD5 MAMLD1 CHD7 WDR76 BRCA1 UTP3 CLSPN PLK4 ZNF292 | 2.39e-04 | 298 | 180 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | KATNAL2 TTC41P ZNF280D ATAD5 LRRC49 CHD7 WDR76 DICER1 BLM RIF1 PSME4 BRCA1 BRCA2 TLE1 VPS13A EXO1 TMEM131L UTP3 CLSPN CAMSAP1 ZNF281 PLK4 KNL1 ZNF292 MYBL2 C1orf174 | 2.56e-04 | 1459 | 180 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | ATAD5 ARHGAP11A WDR76 KIF20A BLM IGSF10 BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 | 2.68e-04 | 422 | 180 | 12 | GSM538355_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 2.74e-04 | 105 | 180 | 6 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000 | HIVEP1 FAM185A CHD7 TEX15 INTS3 LGR5 DHRS1 ZBTB1 DST RESF1 PRDX3 PCDH11X NXF3 NUMB TTC38 ABTB2 ADGRA3 MTSS2 | 2.82e-04 | 837 | 180 | 18 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | SPATA7 KATNAL2 ZNF280D ATAD5 MAMLD1 CHD7 SMG5 ZBTB1 BLM RIF1 BBX BRCA2 PCDH11X KNDC1 NUMB CLSPN KNL1 PPP6R3 MTSS2 ZNF292 | 2.87e-04 | 989 | 180 | 20 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_500 | 3.09e-04 | 16 | 180 | 3 | gudmap_developingGonad_e16.5_testes_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | USP34 RBM44 NEXMIF ASH1L ZNF207 TEX15 EZH1 LGR5 RIF1 BBX RESF1 MAST4 CCNB3 TNRC6A INSYN2B TCFL5 ABTB2 | 3.48e-04 | 778 | 180 | 17 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.49e-04 | 203 | 180 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_500 | RBM44 FAM185A XPO4 TEX15 WDR76 BLM RIF1 BRCA1 BRCA2 EXO1 MYBL2 | 3.80e-04 | 376 | 180 | 11 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | DOCK1 SH3RF1 MYCBP2 VWA8 DOCK8 ABCA13 FNBP4 EZH1 HIPK3 EIF2AK2 GARRE1 | 4.07e-04 | 379 | 180 | 11 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | DOCK1 SH3RF1 MYCBP2 VWA8 DOCK8 ABCA13 FNBP4 CHD7 EZH1 HIPK3 DST PTPRO SCN7A VPS13A SCUBE3 EIF2AK2 GARRE1 | 4.45e-04 | 795 | 180 | 17 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SYNRG RANBP2 KATNAL2 VWA8 ATAD5 MAMLD1 CHD7 RIF1 DST BRCA1 VPS13A EXO1 UTP3 CLSPN ABTB2 | 4.74e-04 | 654 | 180 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | RBM44 NEXMIF ASH1L ZNF207 TEX15 LGR5 RIF1 RESF1 CCNB3 INSYN2B TCFL5 | 4.84e-04 | 387 | 180 | 11 | gudmap_developingGonad_e16.5_ovary_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500 | RBM44 FAM185A TEX15 WDR76 BLM RIF1 BRCA1 BRCA2 EXO1 CLSPN MYBL2 | 4.84e-04 | 387 | 180 | 11 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | DOCK1 MYCBP2 FAM13C ZNF207 LGR5 RYR3 HIPK3 DACT1 DST VPS13A PCDH11X KCNMA1 INSYN2B TSLP ZMYM4 AGTPBP1 ZNF292 | 5.20e-04 | 806 | 180 | 17 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_500 | 5.61e-04 | 120 | 180 | 6 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k1_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#3_top-relative-expression-ranked_500 | 5.62e-04 | 79 | 180 | 5 | gudmap_developingGonad_P2_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.88e-04 | 168 | 180 | 7 | gudmap_developingGonad_P2_ovary_1000_k4 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | ATAD5 WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 5.98e-04 | 397 | 180 | 11 | GSM791143_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#4_top-relative-expression-ranked_200 | 6.14e-04 | 20 | 180 | 3 | gudmap_developingGonad_e16.5_ovary_200_k4 | |
| CoexpressionAtlas | B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3 | ATAD5 WDR76 KIF20A BLM BRCA1 SORCS2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 6.37e-04 | 400 | 180 | 11 | GSM538358_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 6.67e-04 | 124 | 180 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | USP34 PDE4B SH3RF1 FAM13C ATAD5 ZNF207 ITGA1 ARHGAP11A ZBTB1 SPHKAP SCN7A PCDH11X ADAMTS20 ZNF281 TCFL5 AGTPBP1 ZNF292 | 6.84e-04 | 826 | 180 | 17 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | USP34 MAP9 PDE4B MYOT FAM13C RYR3 DACT1 DST LMO7 PTPRO PCDH11X ADAMTS20 INSYN2B TNFAIP3 TSLP TCFL5 MEGF11 | 6.93e-04 | 827 | 180 | 17 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | RBM44 FAM185A TEX15 WDR76 BLM RIF1 BRCA1 BRCA2 EXO1 CLSPN MYBL2 | 7.20e-04 | 406 | 180 | 11 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.95e-04 | 230 | 180 | 8 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3 | ADGRG5 ATAD5 CHD7 WDR76 KIF20A BLM BRCA1 EXO1 CLSPN PLK4 KNL1 | 8.44e-04 | 414 | 180 | 11 | GSM476660_500 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 | 9.30e-04 | 419 | 180 | 11 | GSM538348_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_200 | 9.36e-04 | 23 | 180 | 3 | gudmap_developingGonad_e18.5_epididymis_200_k2 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN2.Th, Lin-/lo CD25hi CD44+ cKit+, Thymus, avg-3 | DYNC2I2 ATAD5 WDR76 KIF20A BLM BRCA1 EXO1 CLSPN ADGRA3 KNL1 MYBL2 | 9.48e-04 | 420 | 180 | 11 | GSM791136_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | ATAD5 ARHGAP11A KIF20A BLM TGFB3 BRCA1 EXO1 CLSPN ABTB2 KNL1 TECPR1 | 9.85e-04 | 422 | 180 | 11 | GSM476658_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 | 9.85e-04 | 422 | 180 | 11 | GSM538357_500 |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | DOCK1 ATAD5 KIF20A BLM BRCA1 BRCA2 P2RY1 EXO1 CLSPN KNL1 MTSS2 | 1.00e-03 | 423 | 180 | 11 | GSM791126_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | SPATA7 ZNF280D ASH1L CHD7 MAST4 BRCA1 BRCA2 VPS13A MARF1 ADAMTS20 TMEM131L ZNF91 CLSPN CAMSAP1 ZMYM4 AGTPBP1 | 1.02e-03 | 780 | 180 | 16 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_500 | 1.17e-03 | 431 | 180 | 11 | gudmap_developingKidney_e13.5_podocyte cells_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | SPATA7 ZNF280D ATAD5 ZBTB1 RIF1 BRCA2 NUMB CLSPN KNL1 MTSS2 ZNF292 | 1.19e-03 | 432 | 180 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | DOCK1 MYCBP2 ZNF207 LGR5 HIPK3 VPS13A PCDH11X ZMYM4 AGTPBP1 ZNF292 | 1.25e-03 | 369 | 180 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.39e-03 | 251 | 180 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | DOCK1 MYCBP2 FAM13C VWA8 RYR3 HIPK3 DACT1 DST PCDH11X SORCS2 ADAMTS20 TMEM131L CAMSAP1 TSLP EIF2AK2 MEGF11 | 1.43e-03 | 806 | 180 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | alpha beta T cells, T.DN4.Th, Lin-/lo CD25- CD44- CD28+, Thymus, avg-3 | 1.43e-03 | 376 | 180 | 10 | GSM791154_500 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_500 | 1.49e-03 | 98 | 180 | 5 | gudmap_developingKidney_e13.5_podocyte cells_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | SH3RF1 ZNF280D ASH1L FNBP4 XPO4 ZNF207 CHD7 JMJD1C RIF1 RESF1 MAST4 TLE3 SPHKAP PCDH11X EXO1 ABTB2 | 1.60e-03 | 815 | 180 | 16 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | B cells, preB.FrD.BM, CD19+ IgM- CD45R+ CD43-, Bone marrow, avg-3 | ARHGAP11A LGR5 KIF20A MAST4 PSME4 SORCS2 TMEM131L CLSPN MBD4 KNL1 | 1.64e-03 | 383 | 180 | 10 | GSM399448_500 |
| CoexpressionAtlas | MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst-Confounder_removed-fold2.0_adjp0.05 | EPRS1 HIVEP1 DYNC2I2 BAZ2B ATAD5 LRRC49 XPO4 CHD7 WDR76 BLM RIF1 BBX SLC25A35 BRCA1 SORCS2 SCUBE3 EXO1 CLSPN CAMSAP1 TCFL5 PLK4 CCDC136 AGTPBP1 ZNF286A | 1.65e-03 | 1479 | 180 | 24 | PCBC_ratio_MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | RBM44 SH3RF1 BAZ2B FNBP4 ZNF207 INTS3 RIF1 BBX RESF1 MAST4 BRCA1 ATXN2 EXO1 NUMB GARRE1 MYBL2 | 1.68e-03 | 819 | 180 | 16 | gudmap_developingGonad_e12.5_testes_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | SPATA7 ZNF280D FAM13C MAMLD1 CHD7 WDR76 ZBTB1 TNRC6A NUMB CLSPN SDK1 MTSS2 ZNF292 | 1.74e-03 | 595 | 180 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_500 | 1.74e-03 | 386 | 180 | 10 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.78e-03 | 261 | 180 | 8 | gudmap_developingGonad_e12.5_epididymis_k1_1000 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | DYNC2I2 ATAD5 ARHGAP11A WDR76 FABP5 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 1.11e-13 | 195 | 186 | 14 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 |
| ToppCell | Healthy/Control-T/NK_proliferative|World / Disease group and Cell class | DYNC2I2 ATAD5 ARHGAP11A WDR76 FABP5 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 1.27e-13 | 197 | 186 | 14 | 4a4d3083938783d6f5b87da02f10e501917da0b4 |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | DYNC2I2 ATAD5 ITGA1 ARHGAP11A WDR76 FABP5 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 1.46e-13 | 199 | 186 | 14 | 47c47ebc318a0b98841ca2656837bbd068899559 |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | DYNC2I2 ATAD5 ITGA1 ARHGAP11A WDR76 FABP5 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 1.46e-13 | 199 | 186 | 14 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 5.14e-13 | 174 | 186 | 13 | 84da9faff088d05233183b425385beb054c92d1b |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ATAD5 ARHGAP11A WDR76 GRM8 BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 7.39e-13 | 179 | 186 | 13 | 88d44b04eb5c079531db663ed98ddb20b60feb9a |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 7.93e-13 | 180 | 186 | 13 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 1.29e-12 | 187 | 186 | 13 | e41e39fd3791acf8ae5376cc5061e196d96868ae |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 1.29e-12 | 187 | 186 | 13 | cefa211ef224e803ea9467882e2ca74d0b1492f1 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 1.29e-12 | 187 | 186 | 13 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ATAD5 LINC00052 ARHGAP11A KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN ZNF726 PLK4 WDR62 KNL1 | 1.29e-12 | 187 | 186 | 13 | 057569c9437219ecc396aa6e673b1178a2273837 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | ATAD5 ARHGAP11A WDR76 BLM CD82 BRCA1 BRCA2 SORCS2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 1.58e-12 | 190 | 186 | 13 | e83fa8b711aa79a1767818474f1c193b674b1c31 |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 2.06e-12 | 194 | 186 | 13 | f39a471293ecc5c5967b00e772b8f48ebc9affbe |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 2.06e-12 | 194 | 186 | 13 | f9070035553bc68106a9e0bdf4b507715a138aba |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 2.06e-12 | 194 | 186 | 13 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 2.06e-12 | 194 | 186 | 13 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 2.06e-12 | 194 | 186 | 13 | e14f66f7584909621b776292fbd52808273fd2ee |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 2.06e-12 | 194 | 186 | 13 | 9bbb124001fba7450f4639f47f9b720a483e7242 |
| ToppCell | mild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | DYNC2I2 ATAD5 ARHGAP11A WDR76 FABP5 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 2.20e-12 | 195 | 186 | 13 | 9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 2.35e-12 | 196 | 186 | 13 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | DYNC2I2 ATAD5 WDR76 FABP5 KIF20A BRCA1 BRCA2 PRDX3 EXO1 CLSPN PLK4 KNL1 MYBL2 | 2.35e-12 | 196 | 186 | 13 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 2.35e-12 | 196 | 186 | 13 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | DYNC2I2 ATAD5 ARHGAP11A WDR76 FABP5 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 2.51e-12 | 197 | 186 | 13 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | DYNC2I2 ATAD5 ARHGAP11A WDR76 FABP5 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 2.51e-12 | 197 | 186 | 13 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | DYNC2I2 ATAD5 ARHGAP11A WDR76 FABP5 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 2.51e-12 | 197 | 186 | 13 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 2.51e-12 | 197 | 186 | 13 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | DYNC2I2 ATAD5 WDR76 FABP5 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 2.51e-12 | 197 | 186 | 13 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 | 2.68e-12 | 198 | 186 | 13 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 2.68e-12 | 198 | 186 | 13 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | DYNC2I2 ATAD5 ARHGAP11A WDR76 FABP5 BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 2.85e-12 | 199 | 186 | 13 | d44cc74d7171d96add61dae821daf774b17d4c69 |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | DYNC2I2 ATAD5 ARHGAP11A WDR76 FABP5 BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 2.85e-12 | 199 | 186 | 13 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 |
| ToppCell | Healthy_donor-T/NK_proliferative|World / disease group, cell group and cell class (v2) | DYNC2I2 ATAD5 WDR76 FABP5 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 2.85e-12 | 199 | 186 | 13 | 1311dfd74b991f48b047a439f04f9bf7dfaa0e7a |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ATAD5 SLCO1B3 ARHGAP11A WDR76 KIF20A BLM BRCA2 EXO1 CLSPN ZNF726 PLK4 WDR62 MYBL2 | 2.85e-12 | 199 | 186 | 13 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd |
| ToppCell | control-T/NK_proliferative|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 3.04e-12 | 200 | 186 | 13 | 1da366e35a05f73253629663eeea1fed4ebd7b52 |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | BAZ2B ATAD5 CHD7 WDR76 BLM IGSF10 BBX BRCA1 BRCA2 EXO1 CLSPN KNL1 MYBL2 | 3.04e-12 | 200 | 186 | 13 | dc1c1506823eaa105f1532c6b5d4efa14e788314 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN ZNF726 PLK4 WDR62 MYBL2 | 3.04e-12 | 200 | 186 | 13 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 3.04e-12 | 200 | 186 | 13 | e4eb915c29909cf8535a3603c68976545c05e54b |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | BAZ2B ATAD5 CHD7 WDR76 BLM IGSF10 BBX BRCA1 BRCA2 EXO1 CLSPN KNL1 MYBL2 | 3.04e-12 | 200 | 186 | 13 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 3.04e-12 | 200 | 186 | 13 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ATAD5 LINC00052 WDR76 GRM8 BLM BRCA1 BRCA2 EXO1 CLSPN WDR62 KNL1 MYBL2 | 6.54e-12 | 167 | 186 | 12 | 108ae6221c6edc63c0ec42c42471b3a15a594043 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN WDR62 KNL1 MYBL2 | 2.18e-11 | 185 | 186 | 12 | 30e041d6f6e310d64809e9d6d93cd30052972f3b |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | DYNC2I2 MAP1A ATAD5 ARHGAP11A KIF20A DST BRCA1 EXO1 CLSPN PLK4 KNL1 MYBL2 | 2.18e-11 | 185 | 186 | 12 | 9d3168c7f0b1d739f78b368969cf5c77ce202b97 |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | DYNC2I2 ATAD5 ARHGAP11A FABP5 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 3.17e-11 | 191 | 186 | 12 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c |
| ToppCell | control-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 3.58e-11 | 193 | 186 | 12 | ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | DYNC2I2 ATAD5 ARHGAP11A WDR76 FABP5 BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 3.80e-11 | 194 | 186 | 12 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | DYNC2I2 ATAD5 ARHGAP11A WDR76 FABP5 BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 3.80e-11 | 194 | 186 | 12 | 3c385d93c5fe1a7817813c492f79fdb94d887357 |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | DYNC2I2 ATAD5 ARHGAP11A WDR76 FABP5 BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 3.80e-11 | 194 | 186 | 12 | 635d0e88f9c542a1d9363066c6cdbc6e44db76c1 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 4.03e-11 | 195 | 186 | 12 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | ATAD5 ARHGAP11A WDR76 BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 4.03e-11 | 195 | 186 | 12 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 4.28e-11 | 196 | 186 | 12 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 4.28e-11 | 196 | 186 | 12 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | ATAD5 ARHGAP11A WDR76 FNDC7 BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 4.54e-11 | 197 | 186 | 12 | 0b1fa881abbfcc54b322fc27124db3f8947af016 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | ATAD5 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 4.54e-11 | 197 | 186 | 12 | 8b616cde333bdbc0c591035ad9e4949155866245 |
| ToppCell | proximal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | ATAD5 ARHGAP11A WDR76 FNDC7 BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 4.54e-11 | 197 | 186 | 12 | 0dd9058aa19d1268ebba9a65555870224b5a5978 |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | ATAD5 ARHGAP11A WDR76 FNDC7 BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 4.54e-11 | 197 | 186 | 12 | 9243617b307acf3df40d93c41cd8d4788699a7ea |
| ToppCell | Dividing_Macrophages-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | ATAD5 ARHGAP11A BLM BRCA2 ZNF66 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 4.67e-11 | 152 | 186 | 11 | e39cfc346b35235546b303e7d73e4d9d7120a5fb |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 | 4.82e-11 | 198 | 186 | 12 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | DYNC2I2 ATAD5 ARHGAP11A WDR76 BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 5.11e-11 | 199 | 186 | 12 | 11c3d9fe811a4619347f47d2b0e94066e3085625 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | DYNC2I2 ATAD5 ARHGAP11A WDR76 BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 5.11e-11 | 199 | 186 | 12 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | DYNC2I2 ATAD5 ARHGAP11A WDR76 BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 5.11e-11 | 199 | 186 | 12 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | DYNC2I2 ATAD5 ARHGAP11A WDR76 BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 5.11e-11 | 199 | 186 | 12 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e |
| ToppCell | Influenza_Severe-T/NK_proliferative|Influenza_Severe / Disease group and Cell class | DYNC2I2 ATAD5 WDR76 FABP5 BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 5.11e-11 | 199 | 186 | 12 | 2508c55f9ffe17b694c70f1283f41ad4a8e83c00 |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | DYNC2I2 ATAD5 ARHGAP11A WDR76 BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 5.11e-11 | 199 | 186 | 12 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c |
| ToppCell | mild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2) | DYNC2I2 ATAD5 ARHGAP11A WDR76 BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 5.11e-11 | 199 | 186 | 12 | df2fcaf01b1b48632f84e7355ef21d20853f0664 |
| ToppCell | (1)_T_cells-(1)_T_cell_dividing|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | DYNC2I2 ATAD5 ARHGAP11A FABP5 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 5.11e-11 | 199 | 186 | 12 | 33afdd1b1b951b360ababf440bc556fd9e1c1db2 |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 5.42e-11 | 200 | 186 | 12 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 |
| ToppCell | (0)_NK_cells-(0)_NK_dividing|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | DYNC2I2 ATAD5 ARHGAP11A WDR76 FABP5 KIF20A BRCA1 BRCA2 CLSPN PLK4 KNL1 MYBL2 | 5.42e-11 | 200 | 186 | 12 | 1a630bb327070ffcb111ec36bd8fd4be3627ca2a |
| ToppCell | mild-T/NK_proliferative|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 MYBL2 | 5.42e-11 | 200 | 186 | 12 | 25b4a1a33348e274bd4457efc0d6faa5421c3d31 |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 5.42e-11 | 200 | 186 | 12 | 381bafdde6492f020ae93ab8fffa6215c631c570 |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | DYNC2I2 ATAD5 ARHGAP11A WDR76 FABP5 KIF20A BRCA1 EXO1 CLSPN PLK4 KNL1 MYBL2 | 5.42e-11 | 200 | 186 | 12 | b6a016132526e910f95bb40038bbb23f301ca023 |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-NoSEP / Disease, Lineage and Cell Type | DYNC2I2 ATAD5 ARHGAP11A WDR76 FABP5 KIF20A BRCA1 BRCA2 EXO1 CLSPN KNL1 MYBL2 | 5.42e-11 | 200 | 186 | 12 | d86119766b9c4f1570cd8045313345f9be46d431 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | DYNC2I2 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 5.42e-11 | 200 | 186 | 12 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | DYNC2I2 ARHGAP11A WDR76 KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 5.42e-11 | 200 | 186 | 12 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed |
| ToppCell | Control-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 MYBL2 | 5.42e-11 | 200 | 186 | 12 | 6cf63dd57f6bc0c42e7182322dd24ff9afbe9186 |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | DYNC2I2 ATAD5 ARHGAP11A WDR76 FABP5 KIF20A BRCA1 EXO1 CLSPN PLK4 KNL1 MYBL2 | 5.42e-11 | 200 | 186 | 12 | fcd16d36f67abf154428242b398b71473f281758 |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | DYNC2I2 ATAD5 ARHGAP11A WDR76 FABP5 KIF20A BRCA1 EXO1 CLSPN PLK4 KNL1 MYBL2 | 5.42e-11 | 200 | 186 | 12 | 146f11b521b4b0c2a69f1ee86fb71011c7658914 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells-Neuroepithelial_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 5.42e-11 | 200 | 186 | 12 | 55501f83409e0174c756a13ad8077f5b59975e27 |
| ToppCell | (3)_MNP-(3)_DC_Monocyte_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | DYNC2I2 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 5.42e-11 | 200 | 186 | 12 | d94fe9bd6ee7c1fed14666f24de41bda014e299b |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells|6m / Sample Type, Dataset, Time_group, and Cell type. | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 KNL1 MYBL2 | 5.42e-11 | 200 | 186 | 12 | b9aad527d3ad5bc701e93fa2afdebf695b2a74bb |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 MYBL2 | 5.42e-11 | 200 | 186 | 12 | 63cc57b9331459efbb73051d174d198a3568b938 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ATAD5 WDR76 KIF20A BLM BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 1.29e-10 | 167 | 186 | 11 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | DYNC2I2 ATAD5 ARHGAP11A KIF20A BRCA2 EXO1 CLSPN TTC38 PLK4 KNL1 MYBL2 | 2.56e-10 | 178 | 186 | 11 | dbde3305e0c6a81593fe614e3f2e746b32cc16a7 |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN WDR62 KNL1 MYBL2 | 2.56e-10 | 178 | 186 | 11 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | AVPR2 ATAD5 TEX15 ARHGAP11A KIF20A BRCA2 P2RY1 EXO1 WDR62 KNL1 | 2.68e-10 | 134 | 186 | 10 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ATAD5 ARHGAP11A KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 2.88e-10 | 180 | 186 | 11 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | ATAD5 KATNA1 ARHGAP11A KIF20A BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 MYBL2 | 3.43e-10 | 183 | 186 | 11 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | ARHGAP11A WDR76 BLM BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 3.86e-10 | 185 | 186 | 11 | 9766216b41ee62bbac4caa25cb98ec5627a24075 |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN WDR62 KNL1 MYBL2 | 4.84e-10 | 189 | 186 | 11 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | DYNC2I2 ATAD5 WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 | 5.12e-10 | 190 | 186 | 11 | 005967c540418b85311308072a07c684f4296aef |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | ATAD5 ARHGAP11A WDR76 KIF20A BRCA1 BRCA2 EXO1 CLSPN WDR62 KNL1 MYBL2 | 5.41e-10 | 191 | 186 | 11 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A DST BRCA1 CLSPN WDR62 KNL1 MYBL2 | 6.05e-10 | 193 | 186 | 11 | 0d85025690c9cd545cba30abc38acbdd6a39b153 |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | DYNC2I2 ATAD5 ARHGAP11A KIF20A BRCA1 BRCA2 EXO1 CLSPN WDR62 KNL1 MYBL2 | 6.39e-10 | 194 | 186 | 11 | a8ae49157ca3f9e8b3f1750a995aee012dc859b6 |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A DST BRCA1 CLSPN WDR62 KNL1 MYBL2 | 6.39e-10 | 194 | 186 | 11 | 2360b5f995b360419de41612368cab9fb61781a1 |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A DST BRCA1 CLSPN WDR62 KNL1 MYBL2 | 6.39e-10 | 194 | 186 | 11 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | ATAD5 WDR76 BLM KIAA1210 BRCA1 BRCA2 EXO1 CLSPN ZNF726 PLK4 MYBL2 | 6.39e-10 | 194 | 186 | 11 | 590a9d4f054e6a3685daf752c9354650fcc7d18a |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A DST BRCA1 CLSPN WDR62 KNL1 MYBL2 | 6.39e-10 | 194 | 186 | 11 | cb39850e9577015b6b9834e98c36b412bae7d462 |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A DST BRCA1 CLSPN WDR62 KNL1 MYBL2 | 6.39e-10 | 194 | 186 | 11 | 408597c9aa302a44b112c1d612c21fbb0227a82a |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A DST BRCA1 CLSPN WDR62 KNL1 MYBL2 | 6.39e-10 | 194 | 186 | 11 | 193cc20fefbd795a4ad59e401a95af47d30603e7 |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | DYNC2I2 ATAD5 WDR76 BRCA1 BRCA2 EXO1 CLSPN PLK4 WDR62 KNL1 MYBL2 | 6.39e-10 | 194 | 186 | 11 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | DYNC2I2 ATAD5 ARHGAP11A WDR76 KIF20A DST BRCA1 CLSPN WDR62 KNL1 MYBL2 | 6.39e-10 | 194 | 186 | 11 | 58406502a8cbcc3037f79a1b6a683df408297ae5 |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.10e-05 | 50 | 110 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Demecolcine | USP34 ZC3H12A PDE4B FAM13C DOCK8 UBR4 FNBP4 ZNF207 WDR76 ZBTB1 JMJD1C BLM RIF1 PSME4 BRCA2 VPS13A EXO1 NUMB TNFAIP3 CLSPN MBD4 ABTB2 | 2.89e-06 | 878 | 185 | 22 | ctd:D003703 |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; PC3; HT_HG-U133A | 4.87e-06 | 196 | 185 | 10 | 4683_DN | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; MCF7; HT_HG-U133A | 5.10e-06 | 197 | 185 | 10 | 6261_UP | |
| Drug | Lucanthone | 9.72e-06 | 212 | 185 | 10 | ctd:D008154 | |
| Drug | daunorubicin HCl; Down 200; 1uM; MCF7; HT_HG-U133A | 2.75e-05 | 191 | 185 | 9 | 7507_DN | |
| Drug | Vincristine | USP34 EPRS1 ZC3H12A PDE4B UBAP2 FAM13C DOCK8 UBR4 FNBP4 ZNF207 ITGA1 WDR76 JMJD1C BLM RIF1 PSME4 PTPRO VPS13A EXO1 NUMB TNFAIP3 CLSPN MBD4 ABTB2 | 3.36e-05 | 1182 | 185 | 24 | ctd:D014750 |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 3.37e-05 | 196 | 185 | 9 | 1708_DN | |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.51e-05 | 197 | 185 | 9 | 7223_DN | |
| Drug | Gliclazide [21187-98-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 3.51e-05 | 197 | 185 | 9 | 2870_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 3.51e-05 | 197 | 185 | 9 | 6240_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 3.65e-05 | 198 | 185 | 9 | 5334_UP | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; HL60; HT_HG-U133A | 3.65e-05 | 198 | 185 | 9 | 2334_DN | |
| Drug | Moxonidine [75438-57-2]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 3.80e-05 | 199 | 185 | 9 | 7343_DN | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; PC3; HT_HG-U133A | 3.80e-05 | 199 | 185 | 9 | 6690_UP | |
| Drug | AC1NSKDT | 3.90e-05 | 77 | 185 | 6 | CID005311297 | |
| Drug | 1i9n | 4.67e-05 | 25 | 185 | 4 | CID000446239 | |
| Disease | Colorectal Carcinoma | PCSK2 MYOT ABCA13 PER1 SLCO1B3 LGR5 DACT1 HOXD9 CCNB3 LMO7 TLR2 VPS13A PCDH11X EXO1 LGR6 ZMYM4 AGTPBP1 ZNF292 | 2.64e-07 | 702 | 177 | 18 | C0009402 |
| Disease | fetuin-B measurement | 2.47e-05 | 10 | 177 | 3 | EFO_0008128 | |
| Disease | colon cancer (is_marker_for) | 2.83e-05 | 59 | 177 | 5 | DOID:219 (is_marker_for) | |
| Disease | Autistic Disorder | 3.03e-05 | 261 | 177 | 9 | C0004352 | |
| Disease | ductal carcinoma in situ (biomarker_via_orthology) | 3.58e-05 | 2 | 177 | 2 | DOID:0060074 (biomarker_via_orthology) | |
| Disease | Hereditary site-specific ovarian cancer syndrome | 3.58e-05 | 2 | 177 | 2 | C4749652 | |
| Disease | Colorectal Neoplasms | 4.82e-05 | 277 | 177 | 9 | C0009404 | |
| Disease | uveal melanoma (is_implicated_in) | 2.13e-04 | 4 | 177 | 2 | DOID:6039 (is_implicated_in) | |
| Disease | Hereditary breast ovarian cancer syndrome | 2.13e-04 | 4 | 177 | 2 | cv:C0677776 | |
| Disease | granulocyte percentage of myeloid white cells | 2.27e-04 | 268 | 177 | 8 | EFO_0007997 | |
| Disease | Neurodevelopmental Disorders | 2.49e-04 | 93 | 177 | 5 | C1535926 | |
| Disease | multisite chronic pain | 2.75e-04 | 95 | 177 | 5 | EFO_0010100 | |
| Disease | Primary microcephaly | 3.00e-04 | 22 | 177 | 3 | C0431350 | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 3.54e-04 | 5 | 177 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | pappalysin-1 measurement | 5.28e-04 | 6 | 177 | 2 | EFO_0802845 | |
| Disease | histidine-rich glycoprotein measurement | 5.28e-04 | 6 | 177 | 2 | EFO_0008155 | |
| Disease | Adult only | 5.28e-04 | 6 | 177 | 2 | C3842001 | |
| Disease | Miller Dieker syndrome | 6.91e-04 | 29 | 177 | 3 | C0265219 | |
| Disease | MYELODYSPLASTIC SYNDROME | 7.14e-04 | 67 | 177 | 4 | C3463824 | |
| Disease | prostate cancer (is_implicated_in) | 7.15e-04 | 117 | 177 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | phosphate measurement | 7.37e-04 | 7 | 177 | 2 | EFO_0010968 | |
| Disease | Prostate cancer, familial | 7.98e-04 | 69 | 177 | 4 | C2931456 | |
| Disease | chronotype measurement | DOCK1 PCSK2 USP34 PDE4B HIVEP1 FAM185A MYCBP2 VWA8 OR9Q1 FNBP4 PER1 P2RY1 NXF3 ADGRA3 | 9.20e-04 | 882 | 177 | 14 | EFO_0008328 |
| Disease | breast ductal carcinoma (is_marker_for) | 9.78e-04 | 8 | 177 | 2 | DOID:3007 (is_marker_for) | |
| Disease | neutrophil percentage of leukocytes | HIVEP1 DOCK8 BAZ2B ATAD5 FNBP4 OSER1 CHD7 ZBTB1 JMJD1C ATXN2 ZNF292 | 1.20e-03 | 610 | 177 | 11 | EFO_0007990 |
| Disease | Pancreatic carcinoma, familial | 1.25e-03 | 9 | 177 | 2 | C2931038 | |
| Disease | hepatitis B (is_implicated_in) | 1.42e-03 | 37 | 177 | 3 | DOID:2043 (is_implicated_in) | |
| Disease | electrocardiography | 1.43e-03 | 530 | 177 | 10 | EFO_0004327 | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.56e-03 | 10 | 177 | 2 | DOID:1969 (implicated_via_orthology) | |
| Disease | Fanconi anemia (is_implicated_in) | 1.56e-03 | 10 | 177 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | coronary artery calcification | 1.66e-03 | 450 | 177 | 9 | EFO_0004723 | |
| Disease | neutrophil count | HIVEP1 SPATA6L MYCBP2 DOCK8 ASH1L GC CHD7 ITGAL JMJD1C AP4E1 BBX BRCA1 ATXN2 TNRC6A SCUBE3 TNFAIP3 ZMYM4 ZNF292 | 1.71e-03 | 1382 | 177 | 18 | EFO_0004833 |
| Disease | Lymphoma | 1.78e-03 | 40 | 177 | 3 | C0024299 | |
| Disease | neutrophil count, eosinophil count | 1.86e-03 | 213 | 177 | 6 | EFO_0004833, EFO_0004842 | |
| Disease | initial pursuit acceleration | 1.89e-03 | 87 | 177 | 4 | EFO_0008434 | |
| Disease | gastrin-releasing peptide measurement | 1.90e-03 | 11 | 177 | 2 | EFO_0022000 | |
| Disease | persulfide dioxygenase ETHE1, mitochondrial measurement | 2.27e-03 | 12 | 177 | 2 | EFO_0008258 | |
| Disease | anxiety disorder, stress-related disorder | 2.27e-03 | 12 | 177 | 2 | EFO_0006788, EFO_0010098 | |
| Disease | non-histone chromosomal protein HMG-14 measurement | 2.27e-03 | 12 | 177 | 2 | EFO_0021872 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.28e-03 | 152 | 177 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | neutrophil count, basophil count | 2.39e-03 | 224 | 177 | 6 | EFO_0004833, EFO_0005090 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.50e-03 | 45 | 177 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | fructose measurement | 2.67e-03 | 13 | 177 | 2 | EFO_0010477 | |
| Disease | Benign tumor of pancreas | 2.67e-03 | 13 | 177 | 2 | C0347284 | |
| Disease | X-24588 measurement | 2.67e-03 | 13 | 177 | 2 | EFO_0800898 | |
| Disease | Metabolic Bone Disorder | 3.11e-03 | 14 | 177 | 2 | C0005944 | |
| Disease | C-X-C motif chemokine 11 measurement | 3.11e-03 | 14 | 177 | 2 | EFO_0008057 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 3.11e-03 | 14 | 177 | 2 | C0677776 | |
| Disease | alpha fetoprotein measurement | 3.14e-03 | 100 | 177 | 4 | EFO_0010583 | |
| Disease | Hepatic fibrosis | 3.19e-03 | 49 | 177 | 3 | HP_0001395 | |
| Disease | gastroesophageal reflux disease | 3.25e-03 | 101 | 177 | 4 | EFO_0003948 | |
| Disease | mean platelet volume | EPM2A SPATA6L DOCK8 MYO9B ATAD5 OR9Q1 CHD7 JMJD1C BBX MAST4 ATXN2 TNRC6A TMEM131L ULK2 | 3.50e-03 | 1020 | 177 | 14 | EFO_0004584 |
| Disease | Osteopenia | 3.57e-03 | 15 | 177 | 2 | C0029453 | |
| Disease | Autosomal recessive primary microcephaly | 3.57e-03 | 15 | 177 | 2 | cv:C3711387 | |
| Disease | free cholesterol in large LDL measurement | 3.58e-03 | 51 | 177 | 3 | EFO_0022176 | |
| Disease | Liver carcinoma | 3.67e-03 | 507 | 177 | 9 | C2239176 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 4.06e-03 | 16 | 177 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | eosinophil measurement | 4.13e-03 | 108 | 177 | 4 | EFO_0803540 | |
| Disease | interleukin-1 beta measurement | 4.21e-03 | 54 | 177 | 3 | EFO_0004812 | |
| Disease | reticulocyte count | USP34 EPRS1 UBAP2 VWA8 MYO9B ASH1L ITGA1 JMJD1C CD82 ATXN2 VPS13A TMEM131L EIF2AK2 MYBL2 | 4.33e-03 | 1045 | 177 | 14 | EFO_0007986 |
| Disease | granulocyte count | 4.43e-03 | 254 | 177 | 6 | EFO_0007987 | |
| Disease | S-adenosylhomocysteine measurement | 4.59e-03 | 17 | 177 | 2 | EFO_0010531 | |
| Disease | Astrocytosis | 4.59e-03 | 17 | 177 | 2 | C3887640 | |
| Disease | plasma protease C1 inhibitor measurement | 4.59e-03 | 17 | 177 | 2 | EFO_0008261 | |
| Disease | Gliosis | 4.59e-03 | 17 | 177 | 2 | C0017639 | |
| Disease | reticulocyte measurement | USP34 UBAP2 VWA8 MYO9B ASH1L PER1 ITGA1 JMJD1C CD82 ATXN2 VPS13A TMEM131L EIF2AK2 MYBL2 | 4.62e-03 | 1053 | 177 | 14 | EFO_0010700 |
| Disease | hepatocellular carcinoma (is_implicated_in) | 4.81e-03 | 181 | 177 | 5 | DOID:684 (is_implicated_in) | |
| Disease | platelet crit | ADGRG5 SPATA6L MAP1A MYO9B LEMD2 OSER1 GC JMJD1C BBX MAST4 ATXN2 TMEM131L NUMB | 5.05e-03 | 952 | 177 | 13 | EFO_0007985 |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 5.14e-03 | 18 | 177 | 2 | EFO_1000649, HP_0000131 | |
| Disease | neutrophil-to-lymphocyte ratio | 5.27e-03 | 185 | 177 | 5 | EFO_0008447 | |
| Disease | Malignant neoplasm of breast | AVPR2 UBR4 PER1 ARHGAP11A GRM6 RIF1 BRCA1 BRCA2 TLE3 EXO1 HRG LGR6 CLSPN ZNF281 | 5.48e-03 | 1074 | 177 | 14 | C0006142 |
| Disease | lung disease severity measurement | 5.65e-03 | 118 | 177 | 4 | EFO_0007744 | |
| Disease | Pancreatic carcinoma | 5.72e-03 | 19 | 177 | 2 | C0235974 | |
| Disease | hippocampal tail volume | 5.72e-03 | 19 | 177 | 2 | EFO_0009398 | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 5.72e-03 | 19 | 177 | 2 | DOID:11198 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CNANSFEGSSTTKSE | 786 | Q6N043 | |
| SECKKTFTESSSLAT | 301 | Q9HBT8 | |
| SLSSVSSSSNAEESK | 1591 | Q96QE3 | |
| AAEALSFTKCSSAIS | 1711 | Q96QE3 | |
| TSPSSVFTSKSFCSL | 211 | P18440 | |
| LSTQFLSCSTAVSEK | 131 | P0CF97 | |
| FVSSFSCSNSLKKTQ | 311 | B3EWF7 | |
| TSDSCNNSISLLSEK | 1771 | Q9NR48 | |
| SLATSACAPISSSKS | 391 | Q5VTM2 | |
| ISSSTSHSDASTKQC | 251 | Q8WY36 | |
| SSKTSFSEAKTASQC | 91 | Q5JRM2 | |
| TSKSSLSDSLVCISE | 1491 | Q68DQ2 | |
| NSFLTSNVASSKSES | 1666 | Q9UIF8 | |
| NSSAESSCTNKSASS | 1091 | Q8IWK6 | |
| SSCTNKSASSFKNSS | 1096 | Q8IWK6 | |
| STDSQNSFASCKLTQ | 226 | P28566 | |
| TFSSENTISSLKGCI | 1381 | Q86UQ4 | |
| SCSDESSNSNSSRKS | 1621 | O75179 | |
| SIDSKSFISISNSSS | 1101 | Q9UPY3 | |
| SSCSFVVEKSKESTA | 1071 | Q9UPW5 | |
| NSCETKSSTSSSQKT | 826 | Q5T5Y3 | |
| KASREATSSTSNFSS | 2446 | Q9P2D1 | |
| DNSSCKTITGVFNSS | 716 | P59510 | |
| KSRTTTESSACESAS | 1081 | Q8WWL7 | |
| ADKSSFISVLQTSSS | 36 | P27701 | |
| STAASVAKESSLASS | 891 | Q9UPM8 | |
| TSSTFTFADLAKSTS | 1941 | P49792 | |
| TKSLTDAASCTVTIN | 451 | Q6ZP01 | |
| TTCTSNVAASNAKLA | 381 | Q68E01 | |
| KCSQISLSQSTTASL | 436 | Q86TP1 | |
| CTTFSDTSSNINSIL | 286 | Q9H4D5 | |
| ASTAAVSSSFKCALT | 31 | P47900 | |
| KESVCSSSTCSLNSS | 926 | A6BM72 | |
| GSQAKTFSTCTSHLT | 231 | Q8NGQ5 | |
| CLNTFFSSLSSLSVS | 311 | A8MTJ6 | |
| CTTSSVSSALANTKD | 126 | P04196 | |
| VSSATSITECDKLSS | 826 | P78559 | |
| SITECDKLSSFATSV | 831 | P78559 | |
| ASFSQATTSTESSVK | 91 | P43366 | |
| EDSCLTSLASSSLKQ | 236 | Q49MG5 | |
| LSSVSVNDCSTSFRA | 741 | Q12791 | |
| NVTSSSSAKFEAALT | 311 | Q8NC56 | |
| KSSCDSTQALVAFSD | 861 | Q9HBX8 | |
| SLKTAFSSLSNVSSE | 3481 | Q03001 | |
| ELTCSTTFSSCTISS | 241 | Q5VTL7 | |
| KDSFIENSSSNCTSG | 841 | Q99700 | |
| ASTSSECVSSKSVSQ | 1426 | Q15652 | |
| ITVDSSSGCLKASTN | 276 | Q8N0U4 | |
| SSLSSFQTSCKFSGN | 441 | Q6ZUT3 | |
| SRCQSTKSAQSTRSS | 381 | P11801 | |
| ETKSCQTASIATASA | 61 | Q96EX3 | |
| CTKSQASSCSLQSSD | 216 | Q9UGM5 | |
| KAESVVSVTSQCSFS | 711 | O15534 | |
| IECSRKSSSSLSDVT | 3291 | Q9NYQ8 | |
| QKSSSSASSEASETC | 351 | Q765P7 | |
| CKTTFFNISASTIVS | 311 | Q8IYT4 | |
| ECSLSKSYSSSSNTL | 21 | Q07343 | |
| SSCLEALSTSSVSFK | 136 | A6NFA0 | |
| LSSSTCITKDSSSFA | 321 | Q14005 | |
| KSSNLSVTTDFSESL | 1146 | Q8WWI1 | |
| SVSCLADSSSLSDIT | 261 | Q8IUZ0 | |
| STSLSSSSKRTECSV | 181 | P28356 | |
| SCSSSLDSIKADGTS | 1846 | Q8NG31 | |
| TFVACDSISKCSSSS | 971 | Q9BZA7 | |
| SLSSLSDEFVCSIKS | 236 | Q96RD7 | |
| KFATITCNLTSSDIS | 1066 | P56199 | |
| CESLETNTSSTKTTY | 886 | O00222 | |
| ASSSTATLTANFTKI | 571 | Q9H422 | |
| TESTLKTTQFSCTLG | 56 | Q01469 | |
| FSSSGSCETRKSQSA | 401 | Q16827 | |
| LAFADACTSSSVTSK | 66 | P0C628 | |
| TSSTFTFADVAKSTS | 966 | A6NKT7 | |
| SEETKCSASLFSSQC | 1286 | P38398 | |
| SSEKSTTAFSATVLN | 1046 | Q6WRI0 | |
| TTAFSATVLNVTCLS | 1051 | Q6WRI0 | |
| NCKLTSSGTQSDDST | 366 | O15303 | |
| EEIISASSSSSKCLS | 306 | P54132 | |
| SLSNSSNSVFSECLS | 171 | Q9NYF0 | |
| SLGSCTISKDSFQIS | 591 | Q14185 | |
| NSSSCSSFQDQKIAS | 1131 | Q8NF50 | |
| FYTSCSRKTSVSQTS | 1671 | P51587 | |
| SFATTCESQSNSLVT | 181 | P19525 | |
| KDNFSTSGIETTCAS | 76 | Q9H0R6 | |
| SRFTKKASCTSSSSS | 541 | O15063 | |
| KASCTSSSSSTNYSI | 546 | O15063 | |
| ESLASSKEFASSCSQ | 231 | Q13495 | |
| SLSSGSNFCSEQKTS | 316 | O95243 | |
| KTLTSDSSSSCISAA | 1681 | Q9Y4F3 | |
| STALPEKSLSCSSSF | 2451 | O15021 | |
| DCSQSLTAFATLAST | 366 | Q9ULL0 | |
| CKTTFFNVSSSTLTS | 266 | O75449 | |
| SSSESLSAKTCSLFL | 1511 | Q76NI1 | |
| SQSSFSACVPSLSSK | 556 | Q14746 | |
| EVAGSTSAKTACLTS | 31 | Q8IYL3 | |
| SAFSSAETTELSGKC | 221 | Q96LJ7 | |
| STQLCTFSSTKDLLS | 181 | Q3KQZ1 | |
| VSKTSAAACAVTDLS | 351 | Q9NQZ2 | |
| TSTDFDGSTSVAQCK | 786 | Q8IX30 | |
| AQSSFKTVNSSSTST | 1646 | Q7Z5N4 | |
| SCDSTQALVTFTSSS | 861 | O75473 | |
| SLSSSDARQKAFSTC | 236 | Q8NH56 | |
| SSADARQKAFSTCTA | 231 | Q8NH53 | |
| SISSLCSQITNAFST | 326 | P49757 | |
| SLSAAFAGSITTSKC | 371 | Q8TC56 | |
| TSSTFTFADVAKSTS | 966 | Q7Z3J3 | |
| SSCIESASKDSSVSC | 881 | Q6P4F7 | |
| SRASSVSKQSSCESI | 1111 | Q2M3C7 | |
| RSDSSSCLDSSQFGK | 281 | Q8N4H0 | |
| SCLDSSQFGKSSSSK | 286 | Q8N4H0 | |
| ATKLSSCDSFTSTIN | 86 | P07814 | |
| KSSSVDSELTSLCQS | 301 | Q9UPR3 | |
| TTNFTKIASFTCKAT | 341 | A2VDJ0 | |
| SSVNCSSEKPLSFSA | 621 | Q9UMZ2 | |
| LSFSAVFSTSKSVST | 631 | Q9UMZ2 | |
| SLCKESFSGQVSSSS | 671 | Q8N3X1 | |
| ALISSRKTSTECASS | 1176 | Q5UIP0 | |
| RKTSTECASSTENSF | 1181 | Q5UIP0 | |
| ATEKSTANDTCSSAA | 1001 | Q9HCM1 | |
| NSTSLSFLDSCNSLT | 426 | P10244 | |
| CVLTSSSDSELQQSS | 861 | Q5QGS0 | |
| GFERSSSSESSTNKC | 711 | Q96PQ0 | |
| EGTSSDSCLTFSASK | 501 | A0A0B4J2F2 | |
| EGTSSDSCLTFSASK | 501 | P57059 | |
| CTSSTLKTNSLTDST | 2936 | O75592 | |
| LKTNSLTDSTCDDSS | 2941 | O75592 | |
| SGSSQAKLFSTSSSC | 46 | P30048 | |
| CFSLQDNSFSSTTVT | 6 | Q8NE31 | |
| LCSSLSISFNSSKHF | 1051 | P20701 | |
| SVTKTQASSSFQDSS | 666 | P46087 | |
| TASGTDISSNSLKDC | 866 | O00444 | |
| KFIHCSTIASSSSSQ | 91 | Q9NX31 | |
| SSNASKLSQCSSKDS | 686 | Q9UQ84 | |
| ALRSQSSTVANCSSK | 96 | Q7Z6J0 | |
| SSTVANCSSKDLQSS | 101 | Q7Z6J0 | |
| SCRSLSLSSSKSNSQ | 26 | Q8N961 | |
| SCDFSGLSLTSATLK | 81 | Q8IZF4 | |
| KSYGSTSSSDTCQKS | 816 | Q96JN2 | |
| TSSSDTCQKSFVSSC | 821 | Q96JN2 | |
| SLATSACAPISSSKS | 346 | A6NIR3 | |
| DSCSLLTKESSHNSS | 761 | Q9HAW4 | |
| KDSLYSSCGTSNSAI | 486 | O95498 | |
| ASIFQSKESSSVLSC | 731 | Q04724 | |
| QNSTYTTSVITSCSL | 586 | Q5T6F2 | |
| SSNVEISSNSCKSEL | 941 | A4D1E1 | |
| ACSILTALLSEFSSS | 156 | Q9C0E2 | |
| TALLSEFSSSSKTSN | 161 | Q9C0E2 | |
| SECGKSFSRSSNLAT | 421 | Q7Z7L9 | |
| STFSSFSLKNCILDD | 1446 | Q96RL7 | |
| SSQSSSLLTESEQCS | 361 | Q5D1E8 | |
| SECGKAFSQSSSLTV | 421 | Q3ZCX4 | |
| SQLSKDTSVLTFTFC | 81 | Q96N35 | |
| CLATLSSLKSTVSAS | 111 | Q99973 | |
| CSTCFKRTTAEASSS | 536 | P21580 | |
| TCLSFSKDSSQILSA | 311 | Q2TAY7 | |
| SISQCTSSSQLDETS | 266 | O95235 | |
| TCLTTSRSQTDKLAF | 121 | Q15413 | |
| ASSTSNIYTQSDVKC | 806 | Q7Z6L1 | |
| CFENLNSTTITLTTS | 196 | Q7Z6K1 | |
| TSSLSTCLINQTLSF | 136 | Q9NPD5 | |
| SCGNFVASSSLDKTS | 446 | Q8N0X2 | |
| SCSNASASAVAETKE | 371 | Q92800 | |
| NRTSNSKTSSIEECS | 1551 | O60281 | |
| TRTSALSAKSCESNS | 86 | P02774 | |
| TSFISSSKTVVQSCG | 576 | Q8IWV7 | |
| STVSSSLSYKSLCAR | 471 | Q6P2S7 | |
| ETSSAFQSSSQKLTS | 776 | Q9Y2X9 | |
| LSTKSNAFCTDSSSL | 26 | Q9P0W8 | |
| SGTKSTEFNNTVSCS | 56 | Q969D9 | |
| LSSTFSTILTQCSKE | 586 | Q14997 | |
| FQSKESSSVLSCDIS | 736 | Q04726 | |
| IQDADCSSSKCSSSA | 116 | Q9Y2K1 | |
| CSSSKCSSSASSKQN | 121 | Q9Y2K1 | |
| TFLATSCSDKSISVI | 686 | O43379 | |
| KDSASTSSKNSSCDT | 336 | Q8IYT8 | |
| EECSKAFSRSSALTT | 456 | A6NNF4 | |
| ASSNSESLSASSKAL | 271 | O43670 | |
| EECGKAFSQSSTLTT | 941 | Q05481 | |
| STTSNEACKLFDATL | 21 | Q5R3I4 | |
| TSSKAESTLQNSSSA | 101 | Q9H967 | |
| TECGKAFNRSSTFTT | 176 | Q6ZN08 | |
| ALVSSFSSCKDVTAE | 726 | Q01118 | |
| SICSSNSKLLDSSED | 931 | Q9UL62 | |
| ADDVSCSSSQVSAKS | 771 | Q70CQ2 | |
| LASTTFPKTASSSVC | 581 | Q9BXT5 | |
| SQLLSFATTLCSQES | 291 | A3KMH1 | |
| TKSGSKSSICESSSL | 3066 | Q5T4S7 | |
| KSSICESSSLISSAT | 3071 | Q5T4S7 | |
| TQSSSNSCSVLEAAK | 276 | Q9UL49 | |
| SLSKEESSNQASLSC | 16 | O60603 | |
| ASFSEFTSSLSTKDS | 721 | Q5H9R7 | |
| SSLSSKTRTDNSECI | 166 | P15822 | |
| NFATVSLSLSTCTTL | 16 | P10600 | |
| SSTSDSSTNCKNAVV | 216 | Q8NDV7 | |
| SQLKSLCASTLTVSS | 351 | Q9ULE0 | |
| TTSKDFCSQSCLSTY | 411 | Q5VZL5 | |
| ESCTTASSSLAKDTS | 356 | P30518 | |
| SNSVKESSSCLSSSH | 641 | A8MT70 | |
| SQDSICSSSQCESSK | 721 | B1ANS9 | |
| DSEKSTSCLNATSVA | 251 | A6NMK8 | |
| QASCRVTATKDSTTS | 31 | Q13459 | |
| QCTEQRFSASSTLSS | 46 | Q9UBF9 | |
| SCSSTLASTFSNGRK | 346 | P16519 |